Barclays PLC 6-K, filed Oct 22, 2026
Barclays PLC (BCS)
6-K
2026-10-22
For: 2026-10-22
View Original
Added on
October 22, 2026
About this 6-K
Barclays PLC filed this 6-K on October 22, 2026.
Barclays reported Q326 RoTE of 11.7%, profit before tax of £2.3bn, and announced a £500m share buyback, bringing year-to-date distributions to £2.8bn. AI summary
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
October
22, 2026
Barclays PLC
(Name
of Registrant)
1 Churchill Place
London E14 5HP
England
(Address
of Principal Executive Office)
Indicate
by check mark whether the registrant files or will file annual
reports
under
cover of Form 20-F or Form 40-F.
Form
20-F x Form 40-F
This
Report on Form 6-K is filed by Barclays PLC.
This
Report comprises:
Information
given to The London Stock Exchange and furnished pursuant
to
General
Instruction B to the General Instructions to Form 6-K.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
BARCLAYS
PLC
|
|
|
(Registrant)
|
Date:
October 22, 2026
|
|
By: /s/
Garth Wright
--------------------------------
|
|
|
Garth
Wright
|
|
|
Assistant
Secretary
|
|
|
Barclays
PLC
Q326 Results Announcement
30 September 2026
Notes
The terms Barclays and Group refer to Barclays PLC together with
its subsidiaries. Unless otherwise stated, the income statement
analysis compares the nine months ended 30 September 2026 to
the corresponding nine months of 2025 and balance sheet analysis as
at 30 September 2026 with comparatives relating to 31 December
2025 and 30 September 2025. The abbreviations
‘£m’ and ‘£bn’ represent millions
and thousands of millions of Pounds Sterling respectively; the
abbreviations ‘$m’ and ‘$bn’ represent
millions and thousands of millions of US Dollars respectively; and
the abbreviations ‘€m’ and
‘€bn’ represent millions and thousands of
millions of Euros respectively.
There are a number of key judgement areas, for example impairment
calculations, which are based on models and which are subject to
ongoing adjustment and modifications. Reported numbers reflect best
estimates and judgements at the given point in time.
Relevant terms that are used in this document but are not defined
under applicable regulatory guidance or International Financial
Reporting Standards (IFRS) are explained in the results glossary,
which can be accessed at home.barclays/investor-relations.
The information in this announcement, which was approved by the
Board of Directors on 21 October 2026, does not comprise
statutory accounts within the meaning of Section 434 of the
Companies Act 2006. Statutory accounts for the year ended
31 December 2025, which contain an unmodified audit report
under Section 495 of the Companies Act 2006 (which does not make
any statements under Section 498 of the Companies Act 2006) have
been delivered to the Registrar of Companies in accordance with
Section 441 of the Companies Act 2006.
These results will be furnished on Form 6-K to the US Securities
and Exchange Commission (SEC) as soon as practicable following
publication of this document. Once furnished to the SEC, a copy of
the Form 6-K will be available from the SEC’s website at
www.sec.gov.
Barclays is a frequent issuer in the debt capital markets and
regularly meets with investors via formal roadshows and other ad
hoc meetings. Consistent with its usual practice, Barclays expects
that from time to time over the coming quarter it will meet with
investors globally to discuss these results and other matters
relating to the Group.
Non-IFRS performance measures
Barclays’ management believes that the non-IFRS performance
measures included in this document provide valuable information to
the readers of the financial statements as they enable the reader
to identify a more consistent basis for comparing the
businesses’ performance between financial periods and provide
more detail concerning the elements of performance which the
managers of these businesses are most directly able to influence or
are relevant for an assessment of the Group. They also reflect an
important aspect of the way in which operating targets are defined
and performance is monitored by Barclays’ management.
However, any non-IFRS performance measures in this document are not
a substitute for IFRS measures and readers should consider the IFRS
measures as well. Refer to the appendix on pages 70 to 79 for
definitions and calculations of non-IFRS performance measures
included throughout this document, and reconciliations to the most
directly comparable IFRS measures.
This document contains certain forward-looking statements within
the meaning of Section 21E of the US Securities Exchange Act of
1934, as amended, and Section 27A of the US Securities Act of 1933,
as amended, with respect to the Group. Barclays cautions readers
that no forward-looking statement is a guarantee of future
performance and that actual results or other financial condition or
performance measures could differ materially from those contained
in the forward-looking statements. Forward-looking statements can
be identified by the fact that they do not relate only to
historical or current facts. Forward-looking statements sometimes
use words such as ‘may’, ‘will’,
‘seek’, ‘continue’, ‘aim’,
‘anticipate’, ‘target’,
‘projected’, ‘expect’,
‘estimate’, ‘intend’, ‘plan’,
‘goal’, ‘believe’, ‘achieve’ or
other words of similar meaning. Forward-looking statements can be
made in writing but also may be made verbally by directors,
officers and employees of the Group (including during management
presentations) in connection with this document. Examples of
forward-looking statements include, among others, statements or
guidance regarding or relating to the Group’s future
financial position, business strategy, income levels, costs, assets
and liabilities, impairment charges, provisions, capital leverage
and other regulatory ratios, capital distributions (including
policy on dividends and share buybacks), return on tangible equity,
projected levels of growth in banking and financial markets,
industry trends, any commitments and targets (including
sustainability-related commitments and targets), plans and
objectives for future operations, International Financial Reporting
Standards (“IFRS”) and other statements that are not
historical or current facts. By their nature, forward-looking
statements involve risk and uncertainty because they relate to
future events and circumstances. Forward-looking statements speak
only as at the date on which they are made. Forward-looking
statements may be affected by a number of factors, including,
without limitation: changes in legislation, regulations,
governmental and regulatory policies, expectations and actions,
voluntary codes of practices and the interpretation thereof,
changes in IFRS and other accounting standards, including practices
with regard to the interpretation and application thereof and
emerging and developing sustainability reporting standards
(including emissions accounting methodologies); changes in tax laws
and practice; the outcome of current and future legal proceedings
and regulatory investigations; the Group’s ability along with
governments and other stakeholders to measure, manage and mitigate
the impacts of climate change effectively or navigate
inconsistencies and conflicts in the manner in which climate policy
is implemented in the regions where the Group operates, including
as a result of the adoption of rules and regulations taking a
different or opposing position on sustainability matters, or other
forms of governmental and regulatory action against sustainability
policies; environmental, social and geopolitical risks and
incidents and similar events beyond the Group’s control;
financial crime; the impact of competition in the banking and
financial services industry; capital, liquidity, leverage and other
regulatory rules and requirements applicable to past, current and
future periods; UK, US, Eurozone and global macroeconomic and
business conditions, including inflation; volatility in credit and
capital markets; market related risks such as changes in interest
rates and foreign exchange rates; reforms to benchmark interest
rates and indices; higher or lower asset valuations; changes in
credit ratings of any entity within the Group or any securities
issued by it; changes in counterparty risk; changes in consumer
behaviour; changes in trade policy, including the imposition of
tariffs or other protectionist measures; the direct and indirect
consequences of the conflicts in the Middle East and Ukraine on
European and global macroeconomic conditions, political stability
and financial markets; changes in US legislation and policy;
developments in the UK’s relationship with the European
Union; the risk of cyberattacks, information or security breaches,
technology failures or operational disruptions and any subsequent
impact on the Group’s reputation, business or operations; the
use of new technology, including artificial intelligence; the
Group’s ability to access funding; and the success of
acquisitions, disposals, joint ventures and other strategic
transactions. A number of these factors are beyond the
Group’s control. As a result, the Group’s actual
financial position, results, financial and non-financial metrics or
performance measures or its ability to meet commitments and targets
may differ materially from the statements or guidance set forth in
the Group’s forward-looking statements. In setting its
targets and outlook for the period 2026-2028, Barclays has made
certain assumptions about the macroeconomic environment, including,
without limitation, inflation, interest and unemployment rates, the
different markets and competitive conditions in which Barclays
operates, and its ability to grow certain businesses and achieve
costs savings and other structural actions. Additional risks and
factors which may impact the Group’s future financial
condition and performance are identified in Barclays PLC’s
filings with the US Securities and Exchange Commission
(“SEC”) (including, without limitation, Barclays
PLC’s Annual Report on Form 20-F for the financial year ended
31 December 2025), which are available on the SEC’s website
at www.sec.gov.
Subject to Barclays PLC's obligations under the applicable laws and
regulations of any relevant jurisdiction (including, without
limitation, the UK and the US) in relation to disclosure and
ongoing information, we undertake no obligation to update publicly
or revise any forward-looking statements, whether as a result of
new information, future events or otherwise.
Performance
Highlights
Barclays delivered a return on
tangible equity (RoTE) of 11.7% in Q326, announced a £500m
share buyback, and is on track to deliver its 2026 and 2028
targets
C. S. Venkatakrishnan, Group Chief Executive,
commented
“I am pleased with the ongoing
momentum of Barclays' operational and financial performance, with
RoTE of 11.7% in Q326 and 13.8% year-to-date. Income of £7.4bn
is up 3% from the same quarter last year. Our cost: income ratio
has improved to 62% from 63%, profit before tax grew by 12% to
£2.3bn, and our earnings per share (EPS) has increased 18%.
With one quarter to go before the end of our original three-year
plan, we have either achieved or are on track to achieve all of our
2026 Group targets. We are confident in and committed to the 2028
targets that we laid out earlier in the year. In Q326 we drove 7%
year-on-year loan growth in
our highest returning UK businesses1,
with particular strength in UK Corporate Bank, up 14% year-on-year.
The Investment Bank delivered strong Equities performance,
offsetting a challenging environment for FICC. Our strong
organic capital generation and common equity tier 1 (CET1) ratio of
14.2% means that we are in a position to announce a new £500m
share buyback tranche today, bringing year-to-date distributions to
£2.8bn, up 46% year-on-year.”
|
●
|
Q326 Group RoTE of 11.7% (Q325: 10.6%) and Q326 YTD Group RoTE of 13.8% (Q325 YTD:
12.3%), on track to deliver greater than 12% in
2026
|
|
|
●
|
Q326 EPS of 12.3p, up 18%
year-on-year and 43.0p in Q326 YTD, up 23%
year-on-year
|
|
|
●
|
UK loan growth of 7% year-on-year1,
with UK Corporate Bank up
14%
|
|
|
|
-
|
£28bn of the planned c.£30bn UK risk weighted assets
(RWAs) growth delivered since 20242,
of which £3bn was delivered in Q326
|
|
●
|
Strong performance in Equities, with Q326 up 47%
year-on-year, reflecting prior
investment in Prime Financing and Equity Derivatives offset by a
challenging environment for FICC (19% reduction
year-on-year)
|
|
|
●
|
Continued operational progress in US Consumer Bank
reflecting growth across partnership
cards, retail deposits, and originated loan balances through Best
Egg
|
|
|
●
|
Structurally reducing the cost base through expected
technology-enabled FTE reductions, creating capacity for further investment in the
business
|
|
|
|
-
|
Q326 structural cost actions (SCAs) of £201m (Q325:
£93m), with a further c.£300m planned in
Q4263
|
|
|
-
|
Group total costs expected to be c.£18.5bn in FY26 and
c.£18.4bn in FY27
|
|
●
|
Strong capital position and increased shareholder
distributions
|
|
|
|
-
|
CET1 ratio of 14.2% and announced intention to initiate a share
buyback of up to £500m (Q325: £500m), bringing YTD
announced distributions to £2.8bn, up 46%
year-on-year
|
|
●
|
Greater capital flexibility following reduction in Pillar 2A
requirements, alongside Basel 3.1 implementation
|
|
|
|
-
|
RWAs expected to increase by £8-15bn on 1 January 2027,
equivalent to a reduction in the CET1 ratio of
30-55bps
|
|
|
-
|
Expect 59bps reduction in the Pillar 2A requirement, lowering the
MDA4
requirement from 12.2% to
11.6%
|
Key financial
metrics:
|
|
RoTE
|
EPS
|
Cost: income ratio
|
LLR
|
Income
|
Profit before tax
|
Attributable profit
|
TNAV per share
|
CET1 ratio
|
Total capital
return5
|
|
Q326
|
11.7%
|
12.3p
|
62%
|
43bps
|
£7.4bn
|
£2.3bn
|
£1.6bn
|
410p
|
14.2%
|
£2.8bn
|
|
Q326 YTD
|
13.8%
|
43.0p
|
57%
|
55bps
|
£23.9bn
|
£8.4bn
|
£5.8bn
|
Q326 Group Performance
Highlights:
|
●
|
Group RoTE increased to 11.7% (Q325: 10.6%), with profit before tax
of £2.3bn (Q325: £2.1bn)
|
|
|
●
|
Group income of £7.4bn increased 3% year-on-year
|
|
|
|
-
|
Group net interest income (NII) excluding Barclays Investment Bank
and Head Office was £3.5bn, up 7% year-on-year, driven by
higher structural hedge income and continued lending
momentum
|
|
|
-
|
Year-on-year NII growth across all operating divisions
|
|
●
|
Group cost: income ratio of 62% (Q325: 63%), with total operating
expenses of £4.6bn, increased 1% year-on-year
|
|
|
|
-
|
Group operating costs increased to £4.6bn (Q325: £4.3bn),
reflecting business growth (including £65m related to changes
in material risk taker (MRT) compensation mix), inflation and
further investment spend (including £201m of Q326 SCAs, with
£110m in Barclays UK), partially offset by c.£200m of
cost efficiency savings
|
|
●
|
Credit impairment charges were £0.5bn, down 20%
year-on-year, reflecting more
normalised charges in the Investment Bank and US Consumer
Bank. The loan loss rate (LLR) was 43bps (Q325:
57bps)
|
|
|
1
|
UK loan growth comprises aggregate growth in loans and advances to
customers across Barclays UK, UKCB and PBWM.
|
|
2
|
Represents RWAs from business growth in Barclays UK, UKCB and PBWM
since January 2024, excluding the effects of securitisations, model
updates and other methodological changes. Also excludes additional
operational risk RWAs related to organic growth.
|
|
3
|
At H126 guided SCAs would be up to £0.5bn for H226, which is
c.£0.3bn higher than usual annual SCA run-rate.
|
|
4
|
Maximum distributable amount.
|
|
5
|
Q326 YTD total capital return: includes the £500m buyback
announced at Q126 Results, the £1.0bn buyback and
c.£0.8bn dividend announced at H126 Results and the £500m
buyback announced at Q326 Results.
|
Q326 Business Performance
Highlights
|
●
|
Barclays UK RoTE was broadly stable at 21.2% (Q325: 21.8%)
as income increased 4%, driven by
higher structural hedge income supported by stable deposits
deposit, offset by costs increasing 6% driven by £110m SCAs
taken in Q326
|
|
●
|
Barclays UK Corporate Bank (UKCB) RoTE increased to 23.5% (Q325:
22.8%) as income increased 10%,
reflecting higher structural hedge income and higher average
deposit and lending balances, partially offset by a cost increase
of 10%, given the non-repeat of Q325 UK regulatory levies
credit
|
|
●
|
Barclays Private Bank and Wealth Management (PBWM) RoTE decreased
to 23.8% (Q325: 26.4%). Income growth was 10%, reflecting 6% higher
client asset and liabilities balances year-on-year. Costs increased
18% reflecting ongoing investments in the wealth
proposition
|
|
●
|
Barclays Investment Bank (IB) RoTE decreased to 9.5% (Q325:
10.1%). Income growth was 1%
and lower impairment charge were more than offset by a 4% increase
in costs including £57m Q326 SCAs and £55m MRT
compensation mix, and higher average allocated tangible
equity
|
|
●
|
Barclays US Consumer Bank (USCB) RoTE decreased to 10.9% (Q325:
13.5%) reflecting broadly
stable income and 14% higher costs reflecting the Best Egg
acquisition (Q326 first full quarter of Best Egg
costs)
|
Group financial targets and
guidance1:
2026
|
●
|
Returns: Group RoTE of greater
than 12%
|
||||
|
●
|
Capital returns2:
plan to return at least £10bn of
capital to shareholders between 2024 and 2026, through dividends
and share buybacks, with a continued preference for
buybacks
|
||||
|
|
-
|
Progressive increase in total capital returns versus
2025
|
|||
|
|
-
|
Share buybacks announced quarterly
|
|||
|
|
-
|
Dividends to be paid semi-annually, including planned £2bn
dividend for 2026
|
|||
|
●
|
Income: Group total income of
c.£31.5bn
|
||||
|
|
-
|
Group NII excluding IB and Head Office greater than £13.7bn
and Barclays UK NII around the middle of the £8.1bn -
£8.3bn guided range
|
|||
|
●
|
Costs: Group cost: income ratio
of high 50s in percentage terms and total costs of
c.£18.5bn
|
||||
|
|
-
|
Run-rate costs in 2026 of c.£18.0bn which exclude additional
SCAs of c.£0.3bn above normal annual run-rate, c.£0.1bn
MRT compensation mix adjustments and c.£0.1bn Motor Finance
provision booked in Q126
|
|||
|
●
|
Impairment: expect Group LLR to
be around the top of the 50-60bps through the cycle
range
|
||||
|
●
|
Capital: CET1 ratio target
range of 13-14%
|
||||
|
|
-
|
IB RWAs mid 50s% of Group RWAs
|
|||
|
|
-
|
Impact of regulatory change on RWAs in line with our prior guidance
of c.£19-26bn
|
|||
|
|
|
-
|
c.£8-15bn RWAs from Basel 3.1, with implementation expected
from 1 January 20273
|
||
|
|
|
|
-
|
Expect Pillar 2A CET1 requirement to reduce by 59bps upon
implementation, reducing MDA to 11.6%
|
|
|
|
|
-
|
c.£11bn RWAs from USCB moving to an Internal Ratings Based
(IRB) model, subject to portfolio changes and regulatory approval,
expected in H2 2027
|
||
|
|
|
|
-
|
Expect minimal change in Pillar 2A requirement upon model
implementation
|
|
|
|
|
|
|
|
|
2027
|
●
|
Costs: Group costs of
c.£18.4bn and Barclays UK cost: income ratio of high
40s%
|
2028
|
●
|
Returns: Group RoTE of greater
than 14%
|
|
|
●
|
Capital returns2:
plan to return greater than £15bn
of capital to shareholders between 2026 and 2028, through dividends
and share buybacks. This provides capacity for additional
investment and growth, exceeding the level of investment in the
current plan
|
|
|
●
|
Income: greater than 5%
compound annual growth rate (CAGR) 2025-2028
|
|
|
●
|
Costs: Group cost: income ratio
of low 50s in percentage terms. Cost target includes total gross
efficiency savings of greater than £2bn in
2026-2028
|
|
|
●
|
Impairment: expect Group LLR of
50-60bps through the cycle
|
|
|
●
|
Capital: CET1 ratio target
range of 13-14%
|
|
|
|
-
|
IB RWAs of c.50% of Group RWAs
|
|
1
|
Targets and guidance are based on management's current expectations
as to the macroeconomic environment and the business and may be
subject to change.
|
|
2
|
This multi-year plan is subject to supervisory and Board approvals,
anticipated financial performance and our published CET1 ratio
target range of 13-14%.
|
|
3
|
Fundamental review of the trading book (FRTB) impact mostly
expected in 2027.
|
|
Barclays Group
results
|
Nine months ended
|
|
Three months ended
|
||||
|
|
30.09.26
|
30.09.25
|
|
|
30.09.26
|
30.09.25
|
|
|
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
|
Barclays
UK
|
6,866
|
6,446
|
7
|
|
2,349
|
2,253
|
4
|
|
Barclays
UK Corporate Bank
|
1,661
|
1,525
|
9
|
|
573
|
522
|
10
|
|
Barclays
Private Bank and Wealth Management
|
1,082
|
1,032
|
5
|
|
369
|
335
|
10
|
|
Barclays
Investment Bank
|
11,115
|
10,263
|
8
|
|
3,129
|
3,083
|
1
|
|
Barclays
US Consumer Bank
|
3,047
|
2,628
|
16
|
|
928
|
941
|
(1)
|
|
Head
Office
|
95
|
169
|
(44)
|
|
17
|
33
|
(48)
|
|
Total income
|
23,866
|
22,063
|
8
|
|
7,365
|
7,167
|
3
|
|
Operating costs
|
(13,438)
|
(12,661)
|
(6)
|
|
(4,565)
|
(4,254)
|
(7)
|
|
UK regulatory levies
|
(95)
|
(84)
|
(13)
|
|
(11)
|
12
|
-
|
|
Litigation and conduct
|
(92)
|
(342)
|
73
|
|
16
|
(255)
|
|
|
Total operating expenses
|
(13,625)
|
(13,087)
|
(4)
|
|
(4,560)
|
(4,497)
|
(1)
|
|
Other net income
|
44
|
48
|
(8)
|
|
20
|
39
|
(49)
|
|
Profit before impairment
|
10,285
|
9,024
|
14
|
|
2,825
|
2,709
|
4
|
|
Credit impairment charges
|
(1,897)
|
(1,744)
|
(9)
|
|
(503)
|
(632)
|
20
|
|
Profit before tax
|
8,388
|
7,280
|
15
|
|
2,322
|
2,077
|
12
|
|
Tax charge
|
(1,791)
|
(1,538)
|
(16)
|
|
(422)
|
(365)
|
(16)
|
|
Profit after tax
|
6,597
|
5,742
|
15
|
|
1,900
|
1,712
|
11
|
|
Non-controlling interests
|
(19)
|
(23)
|
17
|
|
—
|
—
|
|
|
Other equity instrument holders
|
(741)
|
(739)
|
—
|
|
(254)
|
(255)
|
—
|
|
Attributable profit
|
5,837
|
4,980
|
17
|
|
1,646
|
1,457
|
13
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
Return on average tangible shareholders' equity
|
13.8%
|
12.3%
|
|
|
11.7%
|
10.6%
|
|
|
Average tangible shareholders' equity (£bn)
|
56.6
|
54.0
|
|
|
56.4
|
55.1
|
|
|
Cost: income ratio
|
57%
|
59%
|
|
|
62%
|
63%
|
|
|
Loan loss rate (bps)
|
55
|
53
|
|
|
43
|
57
|
|
|
Basic earnings per ordinary share
|
43.0p
|
35.1p
|
23
|
|
12.3p
|
10.4p
|
18
|
|
Dividend per ordinary share
|
5.9p
|
3.0p
|
|
|
|
|
|
|
Share buybacks announced (£m)
|
2,000
|
1,500
|
33
|
|
500
|
500
|
—
|
|
Total payout equivalent per share
|
c.20.7
|
c.13.6p
|
51
|
|
|
|
|
|
Basic weighted average number of shares (m)
|
13,571
|
14,189
|
(4)
|
|
13,426
|
14,045
|
(4)
|
|
Period end number of shares (m)
|
13,379
|
13,996
|
(4)
|
|
|
|
|
|
Period end tangible shareholders' equity (£bn)
|
54.8
|
54.9
|
|
|
|
|
|
|
Balance sheet and capital
management1
|
As at 30.09.26
|
As at 31.12.25
|
As at 30.09.25
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
|
|
|
|
|
|
Gross loans and advances at amortised cost2
|
459.8
|
441.3
|
437.5
|
|
|
|
|
|
Loans and advances at amortised cost
|
454.5
|
430.0
|
426.5
|
|
|
|
|
|
Loans and advances at amortised cost impairment coverage
ratio
|
1.2%
|
1.2%
|
1.2%
|
|
|
|
|
|
Total assets
|
1,737.6
|
1,544.2
|
1,629.2
|
|
|
|
|
|
Deposits at amortised cost
|
599.3
|
585.6
|
575.3
|
|
|
|
|
|
Tangible net asset value per share
|
410p
|
409p
|
392p
|
|
|
|
|
|
Common equity tier 1 ratio
|
14.2%
|
14.3%
|
14.1%
|
|
|
|
|
|
Common equity tier 1 capital
|
52.4
|
51.1
|
50.3
|
|
|
|
|
|
Risk weighted assets
|
369.8
|
356.8
|
357.4
|
|
|
|
|
|
UK leverage ratio
|
4.9%
|
5.1%
|
4.9%
|
|
|
|
|
|
UK leverage exposure
|
1,344.0
|
1,247.3
|
1,285.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Funding and liquidity
|
|
|
|
|
|
|
|
|
Group liquidity pool (£bn)
|
372.2
|
337.8
|
332.9
|
|
|
|
|
|
Liquidity coverage ratio
|
157.0%
|
170.0%
|
174.6%
|
|
|
|
|
|
Net stable funding ratio
|
135.8%
|
135.2%
|
135.3%
|
|
|
|
|
|
Loan: deposit ratio
|
76%
|
73%
|
74%
|
|
|
|
|
|
Customer loan: deposit ratio3
|
64%
|
62%
|
62%
|
|
|
|
|
|
1
|
Refer to pages 58
to
64 for further information on how
capital, RWAs and leverage are calculated.
|
|
2
|
Gross loans and advances at amortised cost comprises: loans and
advances to customers and banks at amortised cost, debt securities,
and portfolios reclassified as held for sale, gross of impairment
allowance, and is the denominator used in the LLR
metric.
|
|
3
|
From Q326, the customer loan to deposit ratio has been introduced,
calculated as loans and advances to customers at amortised cost
divided by customer deposits at amortised cost, to improve
comparability with peers.
|
Group Finance Director’s
Review
Q326 YTD Group
performance
|
●
|
Barclays delivered a profit before tax of £8,388m (Q325 YTD:
£7,280m), RoTE of 13.8% (Q325 YTD: 12.3%) and EPS of 43.0p
(Q325 YTD: 35.1p)
|
|
|
●
|
The Group has a diverse income
profile across businesses and geographies. The 2% year-on-year appreciation of average GBP
against USD negatively impacted income and profits, and positively
impacted credit impairment charges and total operating
expenses
|
|
|
●
|
Group income increased 8% to
£23,866m, as continued
structural hedge momentum, higher income in Global Markets and
Investment Banking fees and the c.£225m gain from the sale of
the American Airlines portfolio (AA portfolio), were partially
offset by retail deposits dynamics and net losses on fair value
lending and cost of hedging in the IB
|
|
|
●
|
Group total operating expenses increased to £13,625m (Q325
YTD: £13,087m)
|
|
|
|
-
|
Group operating costs increased 6% to £13,438m, reflecting
business growth (including higher performance costs reflecting
higher income), inflation, and further investment spend (including
the Best Egg acquisition and higher SCAs), partially offset by
c.£550m of cost efficiency savings and foreign exchange
movements
|
|
|
-
|
Litigation and conduct charges of £92m (Q325 YTD: £342m)
primarily reflected a £105m increase in the provision for the
UK Financial Conduct Authority (FCA) motor finance redress scheme
in Q126. Q325 YTD included a £235m charge for motor finance
redress
|
|
●
|
Credit impairment charges
increased to £1,897m (Q325 YTD: £1,744m),
primarily driven by higher single name
charges year-on-year in IB. Total coverage ratio remained stable at
1.2% (December 2025: 1.2%)
|
|
|
●
|
The effective tax rate (ETR) was 21.4% (Q325 YTD:
21.1%)
|
|
|
●
|
Attributable profit was £5,837m (Q325 YTD:
£4,980m)
|
|
|
●
|
Total assets increased to
£1,737.6bn (December 2025: £1,544.2bn)
driven by higher trading activity in
Global Markets, higher lending across the Group, and growth in the
liquidity pool
|
|
|
●
|
Tangible net asset value (TNAV)
per share was broadly stable at 410p (December 2025: 409p)
as EPS of 43.0p was partially offset
by a 24p reduction from the cash flow hedge reserve and a 15p net
reduction from the impact of share buybacks and dividends paid
during Q326 YTD
|
|
Group capital and
leverage
|
●
|
The CET1 ratio remained broadly stable at 14.2% (December 2025:
14.3%). Taking into account the impact of the £500m share
buyback announced today, the CET1 ratio as of 30 September 2026
would be reduced to 14.0%
|
|
|
●
|
Excluding the marginal increase in the CET1 ratio from the Q226
USCB sale of the AA portfolio and acquisition of Best Egg, other
significant movements were:
|
|
|
|
-
|
150bps increase from attributable profit
|
|
|
-
|
108bps decrease driven by shareholder distributions including the
now completed £1.5bn total share buybacks announced with FY25
and Q126 results, the ongoing £1.0bn share buyback announced
with Q226 results, and the accrual for the FY26
dividend
|
|
|
-
|
58bps decrease due to a £14.9bn increase in RWAs, excluding
the impact of foreign exchange movements, primarily driven by
lending growth in UK businesses and higher activity in
IB
|
|
|
-
|
A £0.2bn increase in CET1 capital due to an increase in the
currency translation reserve was offset by a £1.3bn increase
in RWAs as a result of foreign exchange movements
|
|
●
|
The UK leverage ratio decreased to 4.9% (December 2025: 5.1%)
primarily driven by a £96.7bn increase in leverage exposure to
£1,344.0bn (December 2025: £1,247.3bn), partially offset
by a £1.8bn increase in Tier 1 capital. The increase in
leverage exposure was driven by higher trading activity in Global
Markets and increased lending across the Group
|
|
Group funding and
liquidity
|
●
|
The
liquidity metrics remain above regulatory requirements, underpinned
by well-diversified sources of funding, a stable global deposit
franchise and a highly liquid balance sheet
|
|
●
|
The
liquidity pool was £372.2bn, an increase of £34.3bn from
December 2025. The increase in the liquidity pool was driven by
deposit growth across businesses and increased wholesale
funding
|
|
●
|
The average1
liquidity coverage ratio (LCR) was
157.0% (December 2025: 170.0%), equivalent to a surplus of
£118.4bn (December 2025: £131.2bn)
|
|
●
|
Total
deposits increased to £599.3bn (December 2025: £585.6bn),
primarily driven by growth in the International Corporate Bank
(ICB)
|
|
●
|
The average2
Net Stable Funding Ratio (NSFR) was
135.8% (December 2025: 135.2%), which represents a £173.5bn
surplus (December 2025: £166.3bn) above the 100% regulatory
requirement
|
|
●
|
Wholesale
funding outstanding, excluding repurchase agreements, was
£229.5bn (December 2025: £220.1bn)
|
|
●
|
The
Group issued £9.9bn equivalent of minimum requirement for own
funds and eligible liabilities (MREL) instruments from Barclays PLC
(the Parent company), completing the targeted 2026 MREL issuance
plan within H126. The Group has a strong MREL position with a ratio
of 35.2%, which is in excess of the regulatory requirement of 30.5%
excluding any applicable confidential institution specific
Prudential Regulation Authority (PRA) buffer. The Group remains
above its minimum capital regulatory requirements and applicable
buffers
|
|
1
|
Represents average of the last 12 spot month end
ratios.
|
|
2
|
Represents average of the last four spot quarter end
ratios.
|
Other matters
|
●
|
Motor finance commission
arrangements: In Q126, the FCA
published its final rules for an industry-wide redress scheme for
eligible motor finance customers where a commission was payable by
the lender to the broker. Barclays holds a Motor Finance provision
of £430m as at Q326 (H126: £430m). In Q326, the Upper
Tribunal ordered a suspension of parts of the redress scheme
following four legal challenges to the FCA’s final rules. The
legal challenges are to be heard by the Upper Tribunal in Q127.
These challenges will delay and may otherwise affect the
implementation of the redress scheme although the FCA has indicated
a willingness to consider how, despite such challenges, firms may
be able to pay redress in line with its proposed scheme to certain
cohorts of eligible customers in advance of the Upper Tribunal
hearing. Barclays is considering this option, which would be within
the scope of its existing provision estimate. Given the legal
challenges, the legal and regulatory outcomes and the nature,
extent and timing of any remediation action, remain
uncertain
|
|
●
|
USCB changes in Q226:
|
|
|
|
-
|
American Airlines co-branded credit card portfolio
exit: On 24 April 2026 Barclays
exited its American Airlines co-branded credit card partnership,
releasing £3.6bn of RWAs and generating a gain on sale of
c.£225m
|
|
|
-
|
Best Egg acquisition: On 1 May
2026, Barclays completed the acquisition of Best Egg for
c.£0.6bn1,
comprising
c.£0.5bn goodwill and intangibles, and c.£0.1bn of net
financial assets. Best Egg is a leading US direct-to-consumer
personal loan origination platform focused on prime
borrowers
|
|
●
|
GoHenry acquisition:
On 1 October 2026, Barclays Bank UK
PLC completed the acquisition of GoHenry, a money management
platform for children and young people in the UK. The transaction
is expected to marginally reduce the Group's CET1
ratio
|
|
●
|
One Churchill Place:
On 30 June 2026 Barclays announced it
had acquired a 999-year leasehold interest in its global
headquarters at One Churchill Place, London. The transaction
secures Barclays’ control in its global headquarters, while
providing greater certainty over long-term occupancy costs. The
transaction values the acquired leasehold interest at £750m
and is broadly neutral to the Group’s CET1 ratio and
earnings
|
Anna Cross, Group Finance Director
|
1
|
Subject to customary post-completion purchase price
adjustments.
|
Results by
Business
|
Barclays UK
|
Nine months ended
|
|
Three months ended
|
||||
|
|
30.09.26
|
30.09.25
|
|
|
30.09.26
|
30.09.25
|
|
|
Income statement information
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
|
Net interest income
|
6,059
|
5,638
|
7
|
|
2,073
|
1,961
|
6
|
|
Net fee, commission and other income
|
807
|
808
|
—
|
|
276
|
292
|
(5)
|
|
Total income
|
6,866
|
6,446
|
7
|
|
2,349
|
2,253
|
4
|
|
Operating costs
|
(3,642)
|
(3,472)
|
(5)
|
|
(1,274)
|
(1,189)
|
(7)
|
|
UK regulatory levies
|
(49)
|
(44)
|
(11)
|
|
(5)
|
(1)
|
|
|
Litigation and conduct
|
8
|
(37)
|
|
|
8
|
(8)
|
|
|
Total operating expenses
|
(3,683)
|
(3,553)
|
(4)
|
|
(1,271)
|
(1,198)
|
(6)
|
|
Other net income
|
—
|
—
|
—
|
|
—
|
—
|
—
|
|
Profit before impairment
|
3,183
|
2,893
|
10
|
|
1,078
|
1,055
|
2
|
|
Credit impairment charges
|
(461)
|
(339)
|
(36)
|
|
(123)
|
(102)
|
(21)
|
|
Profit before tax
|
2,722
|
2,554
|
7
|
|
955
|
953
|
—
|
|
Attributable profit
|
1,880
|
1,737
|
8
|
|
666
|
647
|
3
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
20.4%
|
19.6%
|
|
|
21.2%
|
21.8%
|
|
|
Average allocated tangible equity (£bn)
|
12.3
|
11.8
|
|
|
12.6
|
11.9
|
|
|
Cost: income ratio
|
54%
|
55%
|
|
|
54%
|
53%
|
|
|
Loan loss rate (bps)
|
25
|
20
|
|
|
20
|
18
|
|
|
Net interest margin
|
3.70%
|
3.59%
|
|
|
3.69%
|
3.68%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As at 30.09.26
|
As at 31.12.25
|
As at 30.09.25
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
|
|
|
|
|
Gross loans and advances at amortised cost1
|
243.3
|
231.9
|
230.9
|
|
|
|
|
|
Loans and advances to customers at amortised cost
|
225.3
|
216.5
|
213.4
|
|
|
|
|
|
Total assets
|
306.6
|
299.6
|
300.2
|
|
|
|
|
|
Customer deposits at amortised cost
|
246.1
|
244.6
|
241.5
|
|
|
|
|
|
Loan: deposit ratio
|
98%
|
94%
|
95%
|
|
|
|
|
|
Customer loan: deposit ratio2
|
92%
|
89%
|
88%
|
|
|
|
|
|
Risk weighted assets
|
90.6
|
85.8
|
86.7
|
|
|
|
|
|
Period end allocated tangible equity
|
12.6
|
11.8
|
11.9
|
|
|
|
|
|
1
|
Gross loans and advances at amortised cost comprises: loans and
advances to customers and banks at amortised cost, debt securities,
and portfolios reclassified as held for sale, gross of impairment
allowance, and is the denominator used in the LLR
metric.
|
|
2
|
From Q326, the customer loan to deposit ratio has been introduced,
calculated as loans and advances to customers at amortised cost
divided by customer deposits at amortised cost, to improve
comparability with peers.
|
|
Analysis of Barclays
UK
|
Nine months ended
|
|
Three months ended
|
||||
|
30.09.26
|
30.09.25
|
|
|
30.09.26
|
30.09.25
|
|
|
|
Analysis of total income
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
|
Retail Banking
|
5,221
|
4,880
|
7
|
|
1,785
|
1,708
|
5
|
|
Business Banking
|
1,645
|
1,566
|
5
|
|
564
|
545
|
3
|
|
Total income
|
6,866
|
6,446
|
7
|
|
2,349
|
2,253
|
4
|
|
|
|
|
|
|
|
|
|
|
Analysis of credit impairment (charges)/releases
|
|
|
|
|
|
|
|
|
Retail Banking
|
(479)
|
(302)
|
(59)
|
|
(135)
|
(98)
|
(38)
|
|
Business Banking
|
18
|
(37)
|
|
|
12
|
(4)
|
|
|
Total credit impairment charges
|
(461)
|
(339)
|
(36)
|
|
(123)
|
(102)
|
(21)
|
|
|
|
|
|
|
|
|
|
|
|
As at 30.09.26
|
As at 31.12.25
|
As at 30.09.25
|
|
|
|
|
|
Analysis of loans and advances to customers at amortised
cost
|
£bn
|
£bn
|
£bn
|
|
|
|
|
|
Retail Banking
|
207.7
|
198.6
|
195.2
|
|
|
|
|
|
Business Banking
|
17.6
|
17.9
|
18.2
|
|
|
|
|
|
Total loans and advances to customers at amortised
cost
|
225.3
|
216.5
|
213.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Analysis of customer deposits at amortised cost
|
|
|
|
|
|
|
|
|
Retail Banking
|
195.2
|
192.7
|
189.3
|
|
|
|
|
|
Business Banking
|
50.9
|
51.9
|
52.2
|
|
|
|
|
|
Total customer deposits at amortised cost
|
246.1
|
244.6
|
241.5
|
|
|
|
|
Barclays UK
UK retail banking division, trusted by over 20 million customers.
Includes Business Banking, serving small-to-medium sized
enterprises (SMEs) with less than £6.5m in annual revenue. Key
business updates include:
|
●
|
Completed
the acquisition of GoHenry on 1 October 2026, extending our ability
to support children, young people and families through money
management and financial education services
|
|
●
|
Launched
the new Barclays Mobile Banking app in Q326, providing a more
personalised digital banking experience and supporting customers
across a broad range of banking needs
|
Barclays UK delivered a RoTE of 20.4% (Q325 YTD: 19.6%)
supported by stability of deposits
delivering robust income, and underpinned by strong asset
quality.
Income
statement - Q326 YTD compared to Q325
YTD
|
●
|
Profit before tax increased 7% to £2,722m
|
|
●
|
Total income increased 7% to
£6,866m. NII increased 7%
to £6,059m, as higher structural hedge income and lending
growth was partially offset by retail deposit dynamics and mortgage
margin compression. Net fee, commission and other income remained
stable at £807m
|
|
●
|
Total operating expenses
increased 4% to £3,683m, driven by £158m SCAs taken year-to-date and
inflation. Ongoing efficiency savings continue to be reinvested, to
drive sustainable improvement to the cost: income
ratio
|
|
●
|
Credit impairment charges were
£461m (Q325 YTD: £339m), reflecting stable underlying credit performance.
Total charges are higher than those in Q325 YTD, which benefitted
from a recalibration adjustment in the Retail credit cards
portfolio to reflect resilient customer behaviour. Retail credit
cards 30 and 90 day arrears rates were 0.9% (Q325: 0.7%) and 0.3%
(Q325: 0.2%) respectively. The Retail credit cards total coverage
ratio was 4.3% (December 2025: 4.3%)
|
Balance
sheet - 30 September 2026 compared to 31 December
2025
|
●
|
Loans and advances to customers
at amortised cost increased £8.8bn to
£225.3bn, primarily driven
by growth in mortgages,
partially offset by the impact of
securitisations
|
|
●
|
Customer
deposits at amortised cost increased by £1.5bn
to £246.1bn, driven by an increase in Retail
Banking deposits. The customer loan: deposit
ratio1
increased to 92%
(December 2025: 89%)
|
|
●
|
RWAs increased to £90.6bn
(December 2025: £85.8bn), primarily due to growth in mortgages, partially
offset by the securitisation of credit risk
assets
|
|
1
|
From Q326, the customer loan to deposit ratio has been introduced,
calculated as loans and advances to customers at amortised cost
divided by customer deposits at amortised cost, to improve
comparability with peers.
|
|
Barclays UK Corporate
Bank
|
Nine months ended
|
|
Three months ended
|
||||
|
|
30.09.26
|
30.09.25
|
|
|
30.09.26
|
30.09.25
|
|
|
Income statement information
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
|
Net interest income
|
1,244
|
1,084
|
15
|
|
437
|
383
|
14
|
|
Net fee, commission and other income
|
417
|
441
|
(5)
|
|
136
|
139
|
(2)
|
|
Total income
|
1,661
|
1,525
|
9
|
|
573
|
522
|
10
|
|
Operating costs
|
(744)
|
(717)
|
(4)
|
|
(256)
|
(243)
|
(5)
|
|
UK regulatory levies
|
(17)
|
(15)
|
(13)
|
|
(2)
|
9
|
|
|
Litigation and conduct
|
—
|
(39)
|
|
|
—
|
—
|
|
|
Total operating expenses
|
(761)
|
(771)
|
1
|
|
(258)
|
(234)
|
(10)
|
|
Other net income
|
—
|
—
|
—
|
|
—
|
—
|
—
|
|
Profit before impairment
|
900
|
754
|
19
|
|
315
|
288
|
9
|
|
Credit impairment charges
|
(21)
|
(36)
|
42
|
|
(2)
|
(5)
|
60
|
|
Profit before tax
|
879
|
718
|
22
|
|
313
|
283
|
11
|
|
Attributable profit
|
606
|
480
|
26
|
|
218
|
196
|
11
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
21.6%
|
18.8%
|
|
|
23.5%
|
22.8%
|
|
|
Average allocated tangible equity (£bn)
|
3.7
|
3.4
|
|
|
3.7
|
3.4
|
|
|
Cost: income ratio
|
46%
|
51%
|
|
|
45%
|
45%
|
|
|
Loan loss rate (bps)
|
8
|
16
|
|
|
2
|
7
|
|
|
|
|
|
|
|
|
|
|
|
|
As at 30.09.26
|
As at 31.12.25
|
As at 30.09.25
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
|
|
|
|
|
Gross loans and advances at amortised cost1
|
33.2
|
30.2
|
29.2
|
|
|
|
|
|
Loans and advances to customers at amortised cost
|
33.0
|
30.0
|
29.0
|
|
|
|
|
|
Deposits at amortised cost
|
87.2
|
88.7
|
86.7
|
|
|
|
|
|
Customer loan: deposit ratio2
|
38%
|
34%
|
33%
|
|
|
|
|
|
Risk weighted assets
|
27.5
|
26.5
|
25.2
|
|
|
|
|
|
Period end allocated tangible equity
|
3.8
|
3.7
|
3.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine months ended
|
|
Three months ended
|
||||
|
|
30.09.26
|
30.09.25
|
|
|
30.09.26
|
30.09.25
|
|
|
Analysis of total income
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
|
Corporate lending
|
276
|
260
|
6
|
|
91
|
90
|
1
|
|
Transaction banking
|
1,385
|
1,265
|
9
|
|
482
|
432
|
12
|
|
Total income
|
1,661
|
1,525
|
9
|
|
573
|
522
|
10
|
|
1
|
Gross loans and advances at amortised cost comprises: loans and
advances to customers and banks at amortised cost, debt securities,
and portfolios reclassified as held for sale, gross of impairment
allowance, and is the denominator used in the LLR
metric.
|
|
2
|
From Q326, the customer loan to deposit ratio has been introduced,
calculated as loans and advances to customers at amortised cost
divided by customer deposits at amortised cost, to improve
comparability with peers.
|
Barclays UK Corporate
Bank
UKCB offers corporate lending and transaction banking services to
clients with annual revenue greater than £6.5m through to FTSE
350 companies. Trusted banking partner to approximately 13,000
clients1
with an average client relationship of
19 years1.
Key business updates include:
|
●
|
Completed
the roll out of iPortal to all clients, providing easier access to
Barclays' banking services through a single digital platform.
Adoption reached c.45%, and is expected to reach 100% by year-end,
supporting broader use of Barclays' lending, transaction banking
and risk management services
|
UKCB delivered a RoTE of 21.6% (Q325 YTD: 18.8%), reflecting increased income from higher average
deposit and lending balances, and positive operating
jaws.
Income statement - Q326 YTD compared to Q325
YTD
|
●
|
Profit before tax increased 22% to £879m
|
|
●
|
Total income increased 9% to
£1,661m, NII increased 15%
to £1,244m, driven by structural hedge income benefit, and
higher average deposit and lending balances.
Net fee, commission and other income
decreased 5% to £417m, driven by lower liquidity pool
income
|
|
●
|
Total operating expenses
decreased 1% to £761m, reflecting the non-repeat of prior year litigation
and conduct charges, partially offset by higher investment spend to
support business growth and efficiency strategy, with ongoing
efficiency savings offsetting inflationary
headwinds
|
|
●
|
Credit impairment charges were
£21m (Q325 YTD: £36m), reflecting stable underlying credit
performance
|
Balance sheet - 30 September 2026 compared to 31 December
2025
|
●
|
Loans and advances to customers
at amortised cost increased to £33.0bn (December 2025:
£30.0bn), reflecting
continued execution of our lending growth
strategy
|
|
●
|
Deposits at amortised cost
decreased to £87.2bn (December 2025: £88.7bn),
largely reflecting corporate liquidity
environment
|
|
●
|
RWAs increased to £27.5bn
(December 2025: £26.5bn), reflecting higher client lending limits and growth
in lending balances
|
|
1
|
As at 31st August 2026
|
|
Barclays Private Bank and Wealth
Management
|
Nine months ended
|
|
Three months ended
|
||||
|
|
30.09.26
|
30.09.25
|
|
|
30.09.26
|
30.09.25
|
|
|
Income statement information
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
|
Net interest income
|
643
|
597
|
8
|
|
223
|
190
|
17
|
|
Net fee, commission and other income
|
439
|
435
|
1
|
|
146
|
145
|
1
|
|
Total income
|
1,082
|
1,032
|
5
|
|
369
|
335
|
10
|
|
Operating costs
|
(810)
|
(715)
|
(13)
|
|
(289)
|
(243)
|
(19)
|
|
UK regulatory levies
|
(4)
|
(3)
|
(33)
|
|
(1)
|
(1)
|
|
|
Litigation and conduct
|
4
|
1
|
|
|
4
|
1
|
|
|
Total operating expenses
|
(810)
|
(717)
|
(13)
|
|
(286)
|
(243)
|
(18)
|
|
Other net income
|
—
|
—
|
—
|
|
—
|
—
|
—
|
|
Profit before impairment
|
272
|
315
|
(14)
|
|
83
|
92
|
(10)
|
|
Credit impairment (charges)/ releases
|
(8)
|
10
|
|
|
(5)
|
(1)
|
|
|
Profit before tax
|
264
|
325
|
(19)
|
|
78
|
91
|
(14)
|
|
Attributable profit
|
216
|
256
|
(16)
|
|
68
|
72
|
(6)
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
25.4%
|
30.9%
|
|
|
23.8%
|
26.4%
|
|
|
Average allocated tangible equity (£bn)
|
1.1
|
1.1
|
|
|
1.1
|
1.1
|
|
|
Cost: income ratio
|
75%
|
69%
|
|
|
78%
|
73%
|
|
|
Loan loss rate (bps)
|
7
|
(9)
|
|
|
12
|
3
|
|
|
|
|
|
|
|
|
|
|
|
Key facts
|
£bn
|
£bn
|
|
|
£bn
|
£bn
|
|
|
Net new assets under management1
|
2.5
|
2.6
|
|
|
0.6
|
0.7
|
|
|
|
|
|
|
|
|
|
|
|
|
As at 30.09.26
|
As at 31.12.25
|
As at 30.09.25
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
|
|
|
|
|
Gross loans and advances at amortised cost2
|
16.4
|
15.1
|
15.2
|
|
|
|
|
|
Loans and advances to customers at amortised cost
|
16.1
|
14.7
|
14.9
|
|
|
|
|
|
Deposits at amortised cost
|
74.4
|
72.0
|
70.6
|
|
|
|
|
|
Risk weighted assets
|
8.1
|
8.0
|
7.9
|
|
|
|
|
|
Period end allocated tangible equity
|
1.1
|
1.1
|
1.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Invested assets3
|
143.2
|
140.6
|
135.7
|
|
|
|
|
|
Of which:
|
|
|
|
|
|
|
|
|
Assets under
management1
|
56.5
|
52.9
|
51.3
|
|
|
|
|
|
Assets under
supervision1
|
86.7
|
87.7
|
84.4
|
|
|
|
|
|
Client assets and liabilities4
|
234.0
|
227.6
|
221.5
|
|
|
|
|
|
1
|
Refer to page 47 for further information on net new assets under
management, assets under management and assets under
supervision.
|
|
2
|
Gross loans and advances at amortised cost comprises: loans and
advances to customers and banks at amortised cost, debt securities,
and portfolios reclassified as held for sale, gross of impairment
allowance, and is the denominator used in the LLR
metric.
|
|
3
|
Invested assets (held off-balance sheet) represent assets under
management and supervision. Uninvested cash held under an
investment mandate and reported within deposits is excluded from
invested assets.
|
|
4
|
Client assets and liabilities refers to deposits, lending and
invested assets.
|
Barclays Private Bank and Wealth Management
Serving clients across the UK wealth continuum and internationally
in the wealth corridors between the UK, Europe, Middle East and
Asia through an established brand with a full private bank
offering. Key business updates include:
|
●
|
Launched
booking centre in Singapore in Q326, combining local booking
capabilities with access to Barclays’ global offering across
private banking, lending, investments and wealth
planning
|
|
●
|
Launched
Planning and Advice service and removed Direct Investing customer
fees in Q226, reflecting continued focus on enhancing client
offering and supporting long-term growth
|
PBWM delivered a RoTE of 25.4% (Q325 YTD: 30.9%),
reflecting higher costs from ongoing
investment to support future growth and efficiency strategy, and a
higher impairment charge.
Income statement - Q326 YTD compared to Q325 YTD
|
●
|
Profit before tax decreased 19% to £264m
|
|
●
|
Total income increased 5% to
£1,082m, driven by higher
NII from growth in deposit balances, partially offset by deposit
mix, and higher net fee, commission and other income from growth in
assets under management and client transactional
activity
|
|
●
|
Total operating expenses
increased 13% to £810m, reflecting ongoing investment to support business
growth and efficiency strategy, and inflationary headwinds,
partially offset by efficiency savings
|
Balance sheet - 30 September 2026 compared to 31 December
2025
|
●
|
Client assets and liabilities
increased £6.4bn to £234.0bn, driven by net new inflow of deposits, loans and
invested assets and market movements, partly offset by adverse
foreign exchange impact
|
|
●
|
RWAs were stable at £8.1bn (December 2025:
£8.0bn)
|
|
Barclays Investment
Bank
|
Nine months ended
|
|
Three months ended
|
||||
|
|
30.09.26
|
30.09.25
|
|
|
30.09.26
|
30.09.25
|
|
|
Income statement information
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
|
Net interest income
|
1,187
|
978
|
21
|
|
393
|
347
|
13
|
|
Net trading income
|
6,209
|
5,903
|
5
|
|
1,580
|
1,581
|
—
|
|
Net fee, commission and other income
|
3,719
|
3,382
|
10
|
|
1,156
|
1,155
|
—
|
|
Total income
|
11,115
|
10,263
|
8
|
|
3,129
|
3,083
|
1
|
|
Operating costs
|
(6,389)
|
(6,003)
|
(6)
|
|
(2,083)
|
(2,010)
|
(4)
|
|
UK regulatory levies
|
(25)
|
(22)
|
(14)
|
|
(3)
|
5
|
|
|
Litigation and conduct
|
2
|
(20)
|
|
|
—
|
(9)
|
|
|
Total operating expenses
|
(6,412)
|
(6,045)
|
(6)
|
|
(2,086)
|
(2,014)
|
(4)
|
|
Other net income
|
—
|
—
|
—
|
|
—
|
—
|
—
|
|
Profit before impairment
|
4,703
|
4,218
|
11
|
|
1,043
|
1,069
|
(2)
|
|
Credit impairment charges
|
(356)
|
(283)
|
(26)
|
|
(33)
|
(144)
|
77
|
|
Profit before tax
|
4,347
|
3,935
|
10
|
|
1,010
|
925
|
9
|
|
Attributable profit
|
3,035
|
2,798
|
8
|
|
720
|
723
|
—
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
13.5%
|
12.9%
|
|
|
9.5%
|
10.1%
|
|
|
Average allocated tangible equity (£bn)
|
30.0
|
29.0
|
|
|
30.4
|
28.6
|
|
|
Income over average risk weighted assets
|
7.3%
|
6.9%
|
|
|
6.1%
|
6.3%
|
|
|
Cost: income ratio
|
58%
|
59%
|
|
|
67%
|
65%
|
|
|
Loan loss rate (bps)
|
34
|
29
|
|
|
9
|
44
|
|
|
|
|
|
|
|
|
|
|
|
|
As at 30.09.26
|
As at 31.12.25
|
As at 30.09.25
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
|
|
|
|
|
Gross loans and advances at amortised cost1
|
139.6
|
131.0
|
129.8
|
|
|
|
|
|
Loans
and advances to customers at amortised cost
|
76.4
|
70.0
|
68.6
|
|
|
|
|
|
Loans
and advances to banks at amortised cost
|
9.7
|
7.4
|
7.5
|
|
|
|
|
|
Debt
securities at amortised cost
|
52.8
|
52.9
|
53.0
|
|
|
|
|
|
Loans and advances at amortised cost
|
138.9
|
130.3
|
129.1
|
|
|
|
|
|
Trading portfolio assets
|
212.8
|
189.5
|
191.3
|
|
|
|
|
|
Financial assets at fair value through the income
statement
|
198.7
|
183.6
|
263.8
|
|
|
|
|
|
Derivative financial instrument assets
|
308.0
|
251.5
|
222.8
|
|
|
|
|
|
Cash collateral and settlement balances
|
172.2
|
121.6
|
152.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deposits at amortised cost
|
166.4
|
156.1
|
152.8
|
|
|
|
|
|
Derivative financial instrument liabilities
|
298.2
|
240.6
|
252.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk weighted assets
|
206.1
|
196.7
|
199.1
|
|
|
|
|
|
Period end allocated tangible equity
|
30.1
|
28.9
|
29.1
|
|
|
|
|
|
|
Nine months ended
|
|
Three months ended
|
||||
|
|
30.09.26
|
30.09.25
|
|
|
30.09.26
|
30.09.25
|
|
|
Analysis of total income
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
|
FICC
|
4,199
|
4,405
|
(5)
|
|
1,012
|
1,256
|
(19)
|
|
Equities
|
3,387
|
2,522
|
34
|
|
1,010
|
689
|
47
|
|
Global Markets
|
7,586
|
6,927
|
10
|
|
2,022
|
1,945
|
4
|
|
Advisory
|
665
|
462
|
44
|
|
222
|
196
|
13
|
|
Equity
capital markets
|
336
|
222
|
51
|
|
87
|
71
|
23
|
|
Debt
capital markets
|
1,156
|
1,174
|
(2)
|
|
347
|
379
|
(8)
|
|
Banking
fees and underwriting
|
2,157
|
1,858
|
16
|
|
656
|
646
|
2
|
|
Corporate
lending
|
40
|
220
|
(82)
|
|
(13)
|
68
|
|
|
Transaction
banking
|
1,332
|
1,258
|
6
|
|
464
|
424
|
9
|
|
International
Corporate Bank
|
1,372
|
1,478
|
(7)
|
|
451
|
492
|
(8)
|
|
Investment Banking
|
3,529
|
3,336
|
6
|
|
1,107
|
1,138
|
(3)
|
|
Total income
|
11,115
|
10,263
|
8
|
|
3,129
|
3,083
|
1
|
|
1
|
Gross loans and advances at amortised cost comprises: loans and
advances to customers and banks at amortised cost, debt securities,
and portfolios reclassified as held for sale, gross of impairment
allowance, and is the denominator used in the LLR
metric.
|
Barclays Investment Bank
Leading Global Markets business and Investment Banking franchises
operating at scale in the UK and US, including the International
Corporate Bank (FTSE 350 clients and larger). Global Markets
represents around two-thirds of the total Investment Bank income,
while Investment Banking generates around two-thirds of fees in the
US.
IB delivered a RoTE of 13.5% (Q325 YTD: 12.9%), driven by higher Global Markets income,
Investment Banking fees and underwriting income, whilst maintaining
cost and capital discipline, driving positive operating jaws and
improved RWA productivity.
Income statement - Q326 YTD compared to Q325 YTD
|
●
|
Profit before tax increased to £4,347m (Q325 YTD:
£3,935m)
|
||
|
●
|
IB has a diverse income profile across businesses and
geographies. The 2%
appreciation of average GBP against USD adversely impacted income
and profits, and positively impacted credit impairment charges and
total operating expenses
|
||
|
|
Total income increased 8% to £11,115m, including the adverse impact of strengthening
average GBP against USD
|
||
|
|
-
|
Global Markets income increased 10% to £7,586m, driven by
increased income in Equities
|
|
|
|
|
-
|
FICC income was 5% lower at £4,199m, versus a strong prior
year performance, reflecting lower client activity, in rates and
credit into the second half of
Q326, and further adversity in September due to the macroeconomic
environment
|
|
|
|
-
|
Equities income increased 34% to £3,387m, reflecting strategic
growth in Prime Financing balances, and Equity
Derivatives
|
|
|
-
|
Investment Banking income increased 6% to
£3,529m
|
|
|
|
|
-
|
Banking fees and underwriting income increased 16% to £2,157m,
primarily driven by Advisory and Equity Capital Markets, up
44% and 51% respectively,
partially offset by Debt Capital Markets
|
|
|
|
-
|
ICB income decreased 7% to £1,372m. Transaction banking income
increased 6% to £1,332m, as higher income from
growth in deposit balances was
partially offset by margin compression due to change in deposits
product mix. Corporate lending
income decreased to £40m, due to net losses on fair value
lending and cost of hedging (c.£170m)1
|
|
●
|
Total operating expenses
increased to £6,412m
(Q325 YTD: £6,045m), driven by higher performance costs, including MRT
adjustments and SCAs, partially offset by efficiency savings and
the impact of strengthening average GBP against
USD
|
||
|
●
|
Credit impairment charges were
£356m (Q325 YTD: £283m), primarily driven by higher single name charges
year-on-year
|
||
Balance sheet - 30 September 2026 compared to 31 December
2025
|
●
|
Profit before tax increased to £4,347m (Q325 YTD:
£3,935m)
|
|
●
|
Loans and advances at amortised cost increased to £138.9bn
(December 2025: £130.3bn),
driven by increased lending across Global Markets and
Banking
|
|
●
|
Trading portfolio assets increased to £212.8bn (December 2025:
£189.5bn), driven by
increased trading activity to facilitate client demand in Global
Markets
|
|
●
|
Financial assets at fair value through the income statement
increased to £198.7bn (December 2025:
£183.6bn), driven by
increased secured lending in Global Markets
|
|
●
|
Derivative financial instrument assets increased to £308.0bn
(December 2025: £251.5bn) and liabilities increased to
£298.2bn (December 2025: £240.6bn), reflecting an increase in client activity and
mark-to-market in interest rate and equity
derivatives
|
|
●
|
Deposits at amortised cost increased to £166.4bn (December
2025: £156.1bn), driven by
growth in deposits primarily in ICB
|
|
1
|
Q326 YTD included c.£105m of fair value losses on lending and
cost of hedges. Q325 YTD included c.£65m of fair value gains
on lending and cost of hedging.
|
|
Barclays US Consumer
Bank
|
Nine months ended
|
|
Three months ended
|
||||
|
|
30.09.26
|
30.09.25
|
|
|
30.09.26
|
30.09.25
|
|
|
Income statement information
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
|
Net interest income
|
2,304
|
2,044
|
13
|
|
749
|
726
|
3
|
|
Net fee, commission and other income
|
743
|
584
|
27
|
|
179
|
215
|
(17)
|
|
Total income
|
3,047
|
2,628
|
16
|
|
928
|
941
|
(1)
|
|
Operating costs
|
(1,281)
|
(1,210)
|
(6)
|
|
(459)
|
(407)
|
(13)
|
|
UK regulatory levies
|
—
|
—
|
|
|
—
|
—
|
|
|
Litigation and conduct
|
(5)
|
(3)
|
(67)
|
|
(3)
|
—
|
|
|
Total operating expenses
|
(1,286)
|
(1,213)
|
(6)
|
|
(462)
|
(407)
|
(14)
|
|
Other net income
|
—
|
—
|
|
|
—
|
—
|
|
|
Profit before impairment
|
1,761
|
1,415
|
24
|
|
466
|
534
|
(13)
|
|
Credit impairment charges
|
(1,053)
|
(1,090)
|
3
|
|
(340)
|
(379)
|
10
|
|
Profit before tax
|
708
|
325
|
|
|
126
|
155
|
(19)
|
|
Attributable profit
|
521
|
246
|
|
|
92
|
118
|
(22)
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity1
|
19.9%
|
9.4%
|
|
|
10.9%
|
13.5%
|
|
|
Average allocated tangible equity (£bn)
|
3.5
|
3.5
|
|
|
3.4
|
3.5
|
|
|
Cost: income ratio
|
42%
|
46%
|
|
|
50%
|
43%
|
|
|
Loan loss rate (bps)2
|
552
|
489
|
|
|
529
|
505
|
|
|
Net interest margin
|
13.20%
|
10.96%
|
|
|
13.74 %
|
11.50%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As at 30.09.26
|
As at 31.12.25
|
As at 30.09.25
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
|
|
|
|
|
Gross loans and advances at amortised cost3
|
25.5
|
30.6
|
29.8
|
|
|
|
|
|
Loans and advances to customers at amortised cost
|
22.3
|
21.1
|
20.0
|
|
|
|
|
|
Deposits at amortised cost
|
25.1
|
24.2
|
23.7
|
|
|
|
|
|
Risk weighted assets
|
24.3
|
27.4
|
25.8
|
|
|
|
|
|
Period end allocated tangible equity
|
3.3
|
3.8
|
3.5
|
|
|
|
|
|
1
|
Return on average allocated tangible equity, excluding a
c.£225m Q226 gain on sale (recorded in Net fee, commission and
other income), from the AA portfolio exit, was 13.6% for Q326 YTD,
as a result of an adjusted attributable profit of
£357m.
|
|
2
|
Q325 YTD and Q325 LLR include held for sale portfolios to remain
consistent with the treatment of impairment.
|
|
3
|
Gross loans and advances at amortised cost comprises: loans and
advances to customers and banks at amortised cost, debt securities,
and portfolios reclassified as held for sale, gross of impairment
allowance, and is the denominator used in the LLR
metric.
|
Barclays US Consumer Bank
A US co-branded credit card issuer and financial services partner
to 23 million customers, with a direct-to-consumer loan origination
platform in Best Egg and strong online retail deposit offering. Key
business updates include:
|
●
|
Completed the American Airlines portfolio exit and the acquisition
of Best Egg in Q226, strengthening our multi-product digital-only
US Consumer Bank and increasing our ability to serve a wider range
of customer borrowing needs
|
|
●
|
Announced a strategic partnership with Samsung in Q226 under which
Barclays is the contracted provider for a range of financial
products through Samsung's digital wallet ecosystem, extending
access to customers through digital channels
|
USCB delivered a RoTE of 19.9% (Q325 YTD: 9.4%),
reflecting a c.£225m Q226 gain on
sale from the AA portfolio exit, continued operational progress,
with increased income from business growth, higher net interest
margin and positive operating jaws. Excluding the gain on sale of
c.£225m (resulting in an adjusted attributable profit of
£357m), the Q326 YTD RoTE was 13.6%.
Income statement - Q326 YTD compared to Q325 YTD
|
●
|
Profit before tax increased to £708m (Q325 YTD:
£325m)
|
|
●
|
The 2% appreciation of average GBP against USD adversely impacted
income and profits, and positively impacted credit impairment
charges and total operating expenses
|
|
●
|
Total income increased 16% to £3,047m, including the adverse impact of the strengthening
of average GBP against USD. NII increased 13% to £2,304m
including business growth, repricing initiatives and change in
portfolio mix. Net fee, commission and other income increased 27%
to £743m driven by the gain on sale from the AA portfolio, and
the Best Egg acquisition
|
|
●
|
Total operating expenses increased 6% to £1,286m,
driven by the acquisitions of Best Egg
and the GM portfolio, business growth and inflationary headwinds,
partially offset by lower partner related expenses, ongoing
efficiency savings and the strengthening of average GBP against
USD
|
|
●
|
Credit impairment charges were £1,053m (Q325 YTD:
£1,090m), reflecting
broadly stable underlying credit performance, the impact from the
Best Egg acquisition and other portfolio changes. US cards 30 and
90 day arrears rates were stable at 2.9% (Q325: 2.9%) and 1.5%
(Q325: 1.5%) respectively. The USCB total coverage ratio was 10.8%
(December 2025: 11.1%
|
Balance sheet - 30 September 2026 compared to 31 December
2025
|
●
|
Loans and advances to customers at amortised cost were
£22.3bn (December 2025: £21.1bn)
|
|
●
|
Deposits at amortised cost increased
to £25.1bn
(December 2025: £24.2bn),
with growth in retail savings which is in line with USCB's strategy
to grow core deposits
|
|
●
|
RWAs decreased to £24.3bn (December 2025:
£27.4bn), driven by a net
£3.2bn reduction relating to the AA portfolio sale and Best
Egg acquisition
|
|
Head Office
|
Nine months ended
|
|
Three months ended
|
||||
|
|
30.09.26
|
30.09.25
|
|
|
30.09.26
|
30.09.25
|
|
|
Income statement information
|
£m
|
£m
|
% Change
|
|
£m
|
£m
|
% Change
|
|
Net interest income
|
131
|
426
|
(69)
|
|
35
|
138
|
(75)
|
|
Net fee, commission and other income
|
(36)
|
(257)
|
86
|
|
(18)
|
(105)
|
83
|
|
Total income
|
95
|
169
|
(44)
|
|
17
|
33
|
(48)
|
|
Operating costs
|
(572)
|
(544)
|
(5)
|
|
(204)
|
(162)
|
(26)
|
|
UK regulatory levies
|
—
|
—
|
|
|
—
|
—
|
|
|
Litigation and conduct
|
(101)
|
(244)
|
59
|
|
7
|
(239)
|
|
|
Total operating expenses
|
(673)
|
(788)
|
15
|
|
(197)
|
(401)
|
51
|
|
Other net income
|
44
|
48
|
(8)
|
|
20
|
39
|
(49)
|
|
Loss before impairment
|
(534)
|
(571)
|
6
|
|
(160)
|
(329)
|
51
|
|
Credit impairment releases/(charges)
|
2
|
(6)
|
|
|
—
|
(1)
|
|
|
Loss before tax
|
(532)
|
(577)
|
8
|
|
(160)
|
(330)
|
52
|
|
Attributable loss
|
(421)
|
(537)
|
22
|
|
(118)
|
(299)
|
61
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
Average allocated tangible equity (£bn)
|
6.0
|
5.3
|
|
|
5.1
|
6.6
|
|
|
|
|
|
|
|
|
|
|
|
|
As at 30.09.26
|
As at 31.12.25
|
As at 30.09.25
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
|
|
|
|
|
Risk weighted assets
|
13.2
|
12.3
|
12.7
|
|
|
|
|
|
Period end allocated tangible equity
|
4.0
|
7.5
|
5.8
|
|
|
|
|
Income statement - Q326 YTD compared to Q325 YTD
|
●
|
Loss before tax was £532m (Q325 YTD: £577m)
|
|
●
|
Total income decreased to £95m (Q325 YTD: £169m),
driven by hedge accounting, including
a c.£30m loss in Q326, and the impact of the disposal of the
German consumer finance business in Q125
|
|
●
|
Total operating expenses decreased to £673m (Q325 YTD:
£788m), given Q326 YTD
included a £105m charge for FCA motor finance redress. Q325
YTD included a £235m charge for FCA motor finance
redress
|
Balance sheet - 30 September 2026 compared to 31 December
2025
|
●
|
RWAs increased to £13.2bn
(December 2025: £12.3bn), including the net impact of the acquisition of the
long-term leasehold interest in One Churchill
Place
|
Quarterly Results
Summary
|
Barclays Group
|
|
|
|
|
|
|
|
|
|
|
|
|
Q326
|
Q226
|
Q126
|
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
|
Income statement information
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
|
Net interest income
|
3,910
|
3,921
|
3,737
|
|
3,734
|
3,745
|
3,505
|
3,517
|
|
3,500
|
|
Net fee, commission and other income
|
3,455
|
4,417
|
4,426
|
|
3,343
|
3,422
|
3,682
|
4,192
|
|
3,464
|
|
Total income
|
7,365
|
8,338
|
8,163
|
|
7,077
|
7,167
|
7,187
|
7,709
|
|
6,964
|
|
Operating costs
|
(4,565)
|
(4,514)
|
(4,359)
|
|
(4,379)
|
(4,254)
|
(4,149)
|
(4,258)
|
|
(4,244)
|
|
UK regulatory levies
|
(11)
|
—
|
(84)
|
|
(229)
|
12
|
—
|
(96)
|
|
(227)
|
|
Litigation and conduct
|
16
|
(4)
|
(104)
|
|
(50)
|
(255)
|
(76)
|
(11)
|
|
(121)
|
|
Total operating expenses
|
(4,560)
|
(4,518)
|
(4,547)
|
|
(4,658)
|
(4,497)
|
(4,225)
|
(4,365)
|
|
(4,592)
|
|
Other net income/(expenses)
|
20
|
3
|
21
|
|
(25)
|
39
|
(9)
|
18
|
|
—
|
|
Profit before impairment
|
2,825
|
3,823
|
3,637
|
|
2,394
|
2,709
|
2,953
|
3,362
|
|
2,372
|
|
Credit impairment charges
|
(503)
|
(571)
|
(823)
|
|
(535)
|
(632)
|
(469)
|
(643)
|
|
(711)
|
|
Profit before tax
|
2,322
|
3,252
|
2,814
|
|
1,859
|
2,077
|
2,484
|
2,719
|
|
1,661
|
|
Tax charges
|
(422)
|
(731)
|
(638)
|
|
(388)
|
(365)
|
(552)
|
(621)
|
|
(448)
|
|
Profit after tax
|
1,900
|
2,521
|
2,176
|
|
1,471
|
1,712
|
1,932
|
2,098
|
|
1,213
|
|
Non-controlling interests
|
—
|
(19)
|
—
|
|
(18)
|
—
|
(21)
|
(2)
|
|
(20)
|
|
Other equity instrument holders
|
(254)
|
(243)
|
(244)
|
|
(258)
|
(255)
|
(252)
|
(232)
|
|
(228)
|
|
Attributable profit
|
1,646
|
2,259
|
1,932
|
|
1,195
|
1,457
|
1,659
|
1,864
|
|
965
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
|
|
|
Return on average tangible shareholders' equity
|
11.7%
|
16.1%
|
13.5%
|
|
8.5%
|
10.6%
|
12.3%
|
14.0%
|
|
7.5%
|
|
Average tangible shareholders' equity (£bn)
|
56.4
|
56.1
|
57.2
|
|
56.5
|
55.1
|
53.9
|
53.1
|
|
51.5
|
|
Cost: income ratio
|
62%
|
54%
|
56%
|
|
66%
|
63%
|
59%
|
57%
|
|
66%
|
|
Loan loss rate (bps)
|
43
|
51
|
74
|
|
48
|
57
|
44
|
61
|
|
66
|
|
Basic earnings per ordinary share
|
12.3p
|
16.7p
|
14.1p
|
|
8.6p
|
10.4p
|
11.7p
|
13.0p
|
|
6.7p
|
|
Basic weighted average number of shares (m)
|
13,426
|
13,565
|
13,727
|
|
13,883
|
14,045
|
14,211
|
14,314
|
|
14,432
|
|
Period end number of shares (m)
|
13,379
|
13,507
|
13,737
|
|
13,867
|
13,996
|
14,180
|
14,336
|
|
14,420
|
|
Period end tangible shareholders' equity (£bn)
|
54.8
|
57.2
|
55.6
|
|
56.8
|
54.9
|
54.5
|
53.4
|
|
51.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet and capital
management1
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
|
Gross loans and advances at amortised cost2
|
459.8
|
450.4
|
449.9
|
|
441.3
|
437.5
|
428.4
|
430.4
|
|
429.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loans and advances to customers at amortised cost
|
373.1
|
359.3
|
358.3
|
|
352.8
|
346.4
|
339.2
|
338.6
|
|
337.9
|
|
Loans and advances to banks at amortised cost
|
10.5
|
12.0
|
12.0
|
|
8.7
|
9.4
|
8.7
|
9.4
|
|
8.3
|
|
Debt securities at amortised cost
|
70.8
|
73.5
|
68.3
|
|
68.5
|
70.7
|
69.9
|
71.4
|
|
68.2
|
|
Loans and advances at amortised cost
|
454.5
|
444.8
|
438.6
|
|
430.0
|
426.5
|
417.8
|
419.4
|
|
414.5
|
|
Loans and advances at amortised cost impairment coverage
ratio
|
1.2%
|
1.2%
|
1.3%
|
|
1.2%
|
1.2%
|
1.2%
|
1.2%
|
|
1.2%
|
|
Total assets
|
1,737.6
|
1,730.4
|
1,694.8
|
|
1,544.2
|
1,629.2
|
1,598.7
|
1,593.5
|
|
1,518.2
|
|
Deposits at amortised cost
|
599.3
|
594.4
|
587.6
|
|
585.6
|
575.3
|
564.5
|
574.3
|
|
560.7
|
|
Tangible net asset value per share
|
410p
|
423p
|
405p
|
|
409p
|
392p
|
384p
|
372p
|
|
357p
|
|
Common equity tier 1 ratio
|
14.2%
|
14.3%
|
14.1%
|
|
14.3%
|
14.1%
|
14.0%
|
13.9%
|
|
13.6%
|
|
Common equity tier 1 capital
|
52.4
|
52.2
|
51.2
|
|
51.1
|
50.3
|
49.5
|
48.8
|
|
48.6
|
|
Risk weighted assets
|
369.8
|
364.8
|
364.5
|
|
356.8
|
357.4
|
353.0
|
351.3
|
|
358.1
|
|
UK leverage ratio
|
4.9%
|
4.9%
|
4.8%
|
|
5.1%
|
4.9%
|
5.0%
|
5.0%
|
|
5.0%
|
|
UK leverage exposure
|
1,344.0
|
1,345.6
|
1,321.3
|
|
1,247.3
|
1,285.3
|
1,259.8
|
1,252.8
|
|
1,206.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Funding and liquidity
|
|
|
|
|
|
|
|
|
|
|
|
Group liquidity pool (£bn)
|
372.2
|
346.7
|
326.1
|
|
337.8
|
332.9
|
333.7
|
336.3
|
|
296.9
|
|
Liquidity coverage ratio3
|
157.0%
|
157.7%
|
165.4%
|
|
170.0%
|
174.6%
|
177.7%
|
175.3%
|
|
172.4%
|
|
Net stable funding ratio
|
135.8%
|
135.8%
|
135.4%
|
|
135.2%
|
135.3%
|
135.6%
|
136.2%
|
|
134.9%
|
|
Loan: deposit ratio
|
76%
|
75%
|
75%
|
|
73%
|
74%
|
74%
|
73%
|
|
74%
|
|
Customer loan: deposit ratio4
|
64%
|
63%
|
63%
|
|
62%
|
62%
|
62%
|
61%
|
|
62%
|
|
1
|
Refer to pages 58 to 64 for further information on how capital,
RWAs and leverage are calculated.
|
|
2
|
Gross loans and advances at amortised cost comprises: loans and
advances to customers and banks at amortised cost, debt securities,
and portfolios reclassified as held for sale, gross of impairment
allowance, and is the denominator used in the LLR
metric.
|
|
3
|
Represents average of the last 12 spot month end ratios. In June
2025, Barclays implemented a new methodology for calculating net
stress outflows related to secured financing transactions in the
LCR.
|
|
4
|
From Q326, the customer loan to deposit ratio has been introduced,
calculated as customer loans divided by customer deposits, to
provide a customer lending-focused funding metric and improve
comparability with peers.
|
Quarterly Results by
Business
|
Barclays UK
|
|
|
|
|
|
|
|
|
|
|
|
|
Q326
|
Q226
|
Q126
|
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q4241
|
|
Income statement information
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
|
Net interest income
|
2,073
|
2,000
|
1,986
|
|
2,015
|
1,961
|
1,855
|
1,822
|
|
1,815
|
|
Net fee, commission and other income
|
276
|
259
|
272
|
|
247
|
292
|
264
|
252
|
|
800
|
|
Total income
|
2,349
|
2,259
|
2,258
|
|
2,262
|
2,253
|
2,119
|
2,074
|
|
2,615
|
|
Operating costs
|
(1,274)
|
(1,194)
|
(1,174)
|
|
(1,274)
|
(1,189)
|
(1,168)
|
(1,115)
|
|
(1,170)
|
|
UK regulatory levies
|
(5)
|
—
|
(44)
|
|
(41)
|
(1)
|
—
|
(43)
|
|
(36)
|
|
Litigation and conduct
|
8
|
(1)
|
1
|
|
(14)
|
(8)
|
(27)
|
(2)
|
|
(9)
|
|
Total operating expenses
|
(1,271)
|
(1,195)
|
(1,217)
|
|
(1,329)
|
(1,198)
|
(1,195)
|
(1,160)
|
|
(1,215)
|
|
Other net income
|
—
|
—
|
—
|
|
—
|
—
|
—
|
—
|
|
—
|
|
Profit before impairment
|
1,078
|
1,064
|
1,041
|
|
933
|
1,055
|
924
|
914
|
|
1,400
|
|
Credit impairment charges
|
(123)
|
(160)
|
(178)
|
|
(74)
|
(102)
|
(79)
|
(158)
|
|
(283)
|
|
Profit before tax
|
955
|
904
|
863
|
|
859
|
953
|
845
|
756
|
|
1,117
|
|
Attributable profit
|
666
|
623
|
591
|
|
706
|
647
|
580
|
510
|
|
781
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
|
Gross loans and advances at amortised cost2
|
243.3
|
239.8
|
233.6
|
|
231.9
|
230.9
|
228.5
|
227.5
|
|
227.5
|
|
Loans and advances to customers at amortised cost
|
225.3
|
220.8
|
217.8
|
|
216.5
|
213.4
|
211.2
|
209.6
|
|
207.7
|
|
Customer deposits at amortised cost
|
246.1
|
245.6
|
243.9
|
|
244.6
|
241.5
|
241.3
|
243.1
|
|
244.2
|
|
Loan: deposit ratio
|
98%
|
97%
|
95%
|
|
94%
|
95%
|
94%
|
93%
|
|
92%
|
|
Customer loan: deposit ratio3
|
92%
|
90%
|
89%
|
|
89%
|
88%
|
87%
|
86%
|
|
85%
|
|
Risk weighted assets
|
90.6
|
89.0
|
87.5
|
|
85.8
|
86.7
|
86.1
|
85.0
|
|
84.5
|
|
Period end allocated tangible equity
|
12.6
|
12.4
|
12.0
|
|
11.8
|
11.9
|
11.8
|
11.8
|
|
11.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
21.2%
|
20.4%
|
19.7%
|
|
23.8%
|
21.8%
|
19.7%
|
17.4%
|
|
28.0%
|
|
Average allocated tangible equity (£bn)
|
12.6
|
12.2
|
12.0
|
|
11.9
|
11.9
|
11.8
|
11.7
|
|
11.2
|
|
Cost: income ratio
|
54%
|
53%
|
54%
|
|
59%
|
53%
|
56%
|
56%
|
|
46%
|
|
Loan loss rate (bps)
|
20
|
27
|
31
|
|
13
|
18
|
14
|
28
|
|
49
|
|
Net interest margin
|
3.69%
|
3.68%
|
3.72%
|
|
3.72%
|
3.68%
|
3.55%
|
3.55%
|
|
3.53%
|
|
1
|
Q424 includes the day 1 impacts from the acquisition of Tesco Bank:
total Income includes a £556m gain, and credit impairment
charges includes a £209m charge.
|
|
2
|
Gross loans and advances at amortised cost comprises: loans and
advances to customers and banks at amortised cost, debt securities,
and portfolios reclassified as held for sale, gross of impairment
allowance, and is the denominator used in the LLR
metric.
|
|
3
|
From Q326, the customer loan to deposit ratio has been introduced,
calculated as customer loans divided by customer deposits, to
provide a customer lending-focused funding metric and improve
comparability with peers.
|
|
Analysis of Barclays
UK
|
Q326
|
Q226
|
Q126
|
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q4241
|
|
Analysis of total income
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
|
Retail Banking
|
1,785
|
1,711
|
1,725
|
|
1,702
|
1,708
|
1,599
|
1,573
|
|
2,078
|
|
Business Banking
|
564
|
548
|
533
|
|
560
|
545
|
520
|
501
|
|
537
|
|
Total income
|
2,349
|
2,259
|
2,258
|
|
2,262
|
2,253
|
2,119
|
2,074
|
|
2,615
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Analysis of credit impairment (charges)/releases
|
|
|
|
|
|
|
|
|
|
|
|
Retail Banking
|
(135)
|
(165)
|
(179)
|
|
(72)
|
(98)
|
(59)
|
(145)
|
|
(279)
|
|
Business Banking
|
12
|
5
|
1
|
|
(2)
|
(4)
|
(20)
|
(13)
|
|
(4)
|
|
Total credit impairment charges
|
(123)
|
(160)
|
(178)
|
|
(74)
|
(102)
|
(79)
|
(158)
|
|
(283)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Analysis of loans and advances to customers at amortised
cost
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
|
Retail Banking
|
207.7
|
203.1
|
200.1
|
|
198.6
|
195.2
|
192.4
|
190.4
|
|
188.0
|
|
Business Banking
|
17.6
|
17.7
|
17.7
|
|
17.9
|
18.2
|
18.8
|
19.2
|
|
19.7
|
|
Total loans and advances to customers at amortised
cost
|
225.3
|
220.8
|
217.8
|
|
216.5
|
213.4
|
211.2
|
209.6
|
|
207.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Analysis of customer deposits at amortised cost
|
|
|
|
|
|
|
|
|
|
|
|
Retail Banking
|
195.2
|
194.5
|
193.1
|
|
192.7
|
189.3
|
189.3
|
190.8
|
|
191.4
|
|
Business Banking
|
50.9
|
51.1
|
50.8
|
|
51.9
|
52.2
|
52.0
|
52.3
|
|
52.8
|
|
Total customer deposits at amortised cost
|
246.1
|
245.6
|
243.9
|
|
244.6
|
241.5
|
241.3
|
243.1
|
|
244.2
|
|
1
|
Q424 includes the day 1 impacts from the acquisition of Tesco Bank:
total Income includes a £556m gain, and credit impairment
charges includes a £209m charge.
|
|
Barclays UK Corporate
Bank
|
|
|
|
|
|
|
|
|
|
|
|
|
Q326
|
Q226
|
Q126
|
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
|
Income statement information
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
|
Net interest income
|
437
|
413
|
394
|
|
396
|
383
|
359
|
342
|
|
324
|
|
Net fee, commission and other income
|
136
|
145
|
136
|
|
143
|
139
|
160
|
142
|
|
134
|
|
Total income
|
573
|
558
|
530
|
|
539
|
522
|
519
|
484
|
|
458
|
|
Operating costs
|
(256)
|
(249)
|
(239)
|
|
(272)
|
(243)
|
(240)
|
(234)
|
|
(250)
|
|
UK regulatory levies
|
(2)
|
—
|
(15)
|
|
(14)
|
9
|
—
|
(24)
|
|
(14)
|
|
Litigation and conduct
|
—
|
—
|
—
|
|
—
|
—
|
(39)
|
—
|
|
(1)
|
|
Total operating expenses
|
(258)
|
(249)
|
(254)
|
|
(286)
|
(234)
|
(279)
|
(258)
|
|
(265)
|
|
Other net income
|
—
|
—
|
—
|
|
—
|
—
|
—
|
—
|
|
—
|
|
Profit before impairment
|
315
|
309
|
276
|
|
253
|
288
|
240
|
226
|
|
193
|
|
Credit impairment charges
|
(2)
|
(16)
|
(3)
|
|
(1)
|
(5)
|
(12)
|
(19)
|
|
(40)
|
|
Profit before tax
|
313
|
293
|
273
|
|
252
|
283
|
228
|
207
|
|
153
|
|
Attributable profit
|
218
|
201
|
187
|
|
168
|
196
|
142
|
142
|
|
98
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
|
Gross loans and advances at amortised cost1
|
33.2
|
31.4
|
31.0
|
|
30.2
|
29.2
|
28.2
|
27.0
|
|
25.8
|
|
Loans and advances to customers at amortised cost
|
33.0
|
31.3
|
30.8
|
|
30.0
|
29.0
|
27.9
|
26.7
|
|
25.4
|
|
Deposits at amortised cost
|
87.2
|
89.1
|
88.0
|
|
88.7
|
86.7
|
85.3
|
85.3
|
|
83.1
|
|
Customer loan: deposit ratio2
|
38%
|
35%
|
35%
|
|
34%
|
33%
|
33%
|
31%
|
|
31%
|
|
Risk weighted assets
|
27.5
|
26.6
|
27.3
|
|
26.5
|
25.2
|
25.3
|
24.2
|
|
23.9
|
|
Period end allocated tangible equity
|
3.8
|
3.7
|
3.7
|
|
3.7
|
3.4
|
3.5
|
3.4
|
|
3.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
23.5%
|
21.3 %
|
19.9%
|
|
19.1%
|
22.8%
|
16.6%
|
17.1%
|
|
12.3%
|
|
Average allocated tangible equity (£bn)
|
3.7
|
3.8
|
3.8
|
|
3.5
|
3.4
|
3.4
|
3.3
|
|
3.2
|
|
Cost: income ratio
|
45%
|
45%
|
48%
|
|
53%
|
45%
|
54%
|
53%
|
|
58%
|
|
Loan loss rate (bps)
|
2
|
20
|
4
|
|
1
|
7
|
17
|
28
|
|
62
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Analysis of total income
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
|
Corporate lending
|
91
|
96
|
89
|
|
97
|
90
|
90
|
80
|
|
71
|
|
Transaction banking
|
482
|
462
|
441
|
|
442
|
432
|
429
|
404
|
|
387
|
|
Total income
|
573
|
558
|
530
|
|
539
|
522
|
519
|
484
|
|
458
|
|
1
|
Gross loans and advances at amortised cost comprises: loans and
advances to customers and banks at amortised cost, debt securities,
and portfolios reclassified as held for sale, gross of impairment
allowance, and is the denominator used in the LLR
metric.
|
|
2
|
From Q326, the customer loan to deposit ratio has been introduced,
calculated as customer loans divided by customer deposits, to
provide a customer lending-focused funding metric and improve
comparability with peers.
|
|
Barclays Private Bank and Wealth
Management
|
|
|
|
|
|
|
|
|
|
|
|
|
Q326
|
Q226
|
Q126
|
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
|
Income statement information
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
|
Net interest income
|
223
|
216
|
204
|
|
202
|
190
|
203
|
204
|
|
216
|
|
Net fee, commission and other income
|
146
|
150
|
143
|
|
146
|
145
|
145
|
145
|
|
135
|
|
Total income
|
369
|
366
|
347
|
|
348
|
335
|
348
|
349
|
|
351
|
|
Operating costs
|
(289)
|
(267)
|
(254)
|
|
(279)
|
(243)
|
(238)
|
(234)
|
|
(255)
|
|
UK regulatory levies
|
(1)
|
—
|
(3)
|
|
(7)
|
(1)
|
—
|
(2)
|
|
(7)
|
|
Litigation and conduct
|
4
|
—
|
—
|
|
(10)
|
1
|
—
|
—
|
|
(1)
|
|
Total operating expenses
|
(286)
|
(267)
|
(257)
|
|
(296)
|
(243)
|
(238)
|
(236)
|
|
(263)
|
|
Other net income
|
—
|
—
|
—
|
|
—
|
—
|
—
|
—
|
|
—
|
|
Profit before impairment
|
83
|
99
|
90
|
|
52
|
92
|
110
|
113
|
|
88
|
|
Credit impairment (charges)/releases
|
(5)
|
(5)
|
2
|
|
(2)
|
(1)
|
2
|
9
|
|
(2)
|
|
Profit before tax
|
78
|
94
|
92
|
|
50
|
91
|
112
|
122
|
|
86
|
|
Attributable profit
|
68
|
75
|
73
|
|
35
|
72
|
88
|
96
|
|
63
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
|
Gross loans and advances at amortised cost1
|
16.4
|
15.1
|
15.1
|
|
15.1
|
15.2
|
14.8
|
14.8
|
|
14.7
|
|
Loans and advances to customers at amortised cost
|
16.1
|
14.8
|
14.7
|
|
14.7
|
14.9
|
14.5
|
14.5
|
|
14.5
|
|
Deposits at amortised cost
|
74.4
|
72.7
|
73.3
|
|
72.0
|
70.6
|
66.7
|
73.1
|
|
69.5
|
|
Risk weighted assets
|
8.1
|
8.0
|
8.2
|
|
8.0
|
7.9
|
7.9
|
8.0
|
|
7.9
|
|
Period end allocated tangible equity
|
1.1
|
1.1
|
1.1
|
|
1.1
|
1.1
|
1.1
|
1.1
|
|
1.1
|
|
Client assets and liabilities2
|
234.0
|
230.2
|
223.8
|
|
227.6
|
221.5
|
213.4
|
212.4
|
|
208.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
23.8%
|
26.9 %
|
25.5 %
|
|
12.6 %
|
26.4%
|
31.9%
|
34.5%
|
|
23.9%
|
|
Average allocated tangible equity (£bn)
|
1.1
|
1.1
|
1.1
|
|
1.1
|
1.1
|
1.1
|
1.1
|
|
1.1
|
|
Cost: income ratio
|
78%
|
73%
|
74%
|
|
85%
|
73%
|
68%
|
68%
|
|
75%
|
|
Loan loss rate (bps)
|
12
|
13
|
(6)
|
|
5
|
3
|
(5)
|
(25)
|
|
5
|
|
1
|
Gross loans and advances at amortised cost comprises: loans and
advances to customers and banks at amortised cost, debt securities,
and portfolios reclassified as held for sale, gross of impairment
allowance, and is the denominator used in the LLR
metric.
|
|
2
|
Client assets and liabilities refers to deposits, lending and
invested assets.
|
|
Barclays Investment
Bank
|
|
|
|
|
|
|
|
|
|
|
|
|
Q326
|
Q226
|
Q126
|
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
|
Income statement information
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
|
Net interest income
|
393
|
411
|
383
|
|
356
|
347
|
334
|
297
|
|
284
|
|
Net trading income
|
1,580
|
2,271
|
2,358
|
|
1,294
|
1,581
|
1,906
|
2,416
|
|
1,262
|
|
Net fee, commission and other income
|
1,156
|
1,276
|
1,287
|
|
1,142
|
1,155
|
1,067
|
1,160
|
|
1,061
|
|
Total income
|
3,129
|
3,958
|
4,028
|
|
2,792
|
3,083
|
3,307
|
3,873
|
|
2,607
|
|
Operating costs
|
(2,083)
|
(2,199)
|
(2,107)
|
|
(1,924)
|
(2,010)
|
(1,932)
|
(2,061)
|
|
(1,903)
|
|
UK regulatory levies
|
(3)
|
—
|
(22)
|
|
(159)
|
5
|
—
|
(27)
|
|
(161)
|
|
Litigation and conduct
|
—
|
—
|
2
|
|
(8)
|
(9)
|
(8)
|
(3)
|
|
(26)
|
|
Total operating expenses
|
(2,086)
|
(2,199)
|
(2,127)
|
|
(2,091)
|
(2,014)
|
(1,940)
|
(2,091)
|
|
(2,090)
|
|
Other net income
|
—
|
—
|
—
|
|
—
|
—
|
—
|
—
|
|
—
|
|
Profit before impairment
|
1,043
|
1,759
|
1,901
|
|
701
|
1,069
|
1,367
|
1,782
|
|
517
|
|
Credit impairment charges
|
(33)
|
(44)
|
(279)
|
|
(22)
|
(144)
|
(67)
|
(72)
|
|
(46)
|
|
Profit before tax
|
1,010
|
1,715
|
1,622
|
|
679
|
925
|
1,300
|
1,710
|
|
471
|
|
Attributable profit
|
720
|
1,204
|
1,111
|
|
294
|
723
|
876
|
1,199
|
|
247
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
|
Gross loans and advances at amortised cost1
|
139.6
|
137.2
|
137.4
|
|
131.0
|
129.8
|
126.8
|
129.6
|
|
124.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loans
and advances to customers at amortised cost
|
76.4
|
70.8
|
73.6
|
|
70.0
|
68.6
|
66.8
|
68.6
|
|
69.7
|
|
Loans
and advances to banks at amortised cost
|
9.7
|
11.0
|
10.0
|
|
7.4
|
7.5
|
7.1
|
7.4
|
|
6.8
|
|
Debt
securities at amortised cost
|
52.8
|
54.5
|
52.9
|
|
52.9
|
53.0
|
52.4
|
53.1
|
|
47.9
|
|
Loans and advances at amortised cost
|
138.9
|
136.3
|
136.5
|
|
130.3
|
129.1
|
126.3
|
129.1
|
|
124.4
|
|
Trading portfolio assets
|
212.8
|
208.2
|
189.3
|
|
189.5
|
191.3
|
186.1
|
185.5
|
|
166.1
|
|
Derivative financial instrument assets
|
308.0
|
302.6
|
285.4
|
|
251.5
|
263.8
|
279.0
|
253.6
|
|
291.6
|
|
Financial assets at fair value through the income
statement
|
198.7
|
209.9
|
215.6
|
|
183.6
|
222.8
|
215.2
|
209.5
|
|
190.4
|
|
Cash collateral and settlement balances
|
172.2
|
182.5
|
189.2
|
|
121.6
|
152.1
|
145.0
|
148.8
|
|
111.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deposits at amortised cost
|
166.4
|
162.3
|
157.4
|
|
156.1
|
152.8
|
148.7
|
148.9
|
|
140.5
|
|
Derivative financial instrument liabilities
|
298.2
|
291.6
|
272.6
|
|
240.6
|
252.0
|
265.1
|
245.1
|
|
279.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Risk weighted assets
|
206.1
|
204.1
|
201.7
|
|
196.7
|
199.1
|
196.4
|
195.9
|
|
198.8
|
|
Period end allocated tangible equity
|
30.1
|
30.1
|
29.6
|
|
28.9
|
29.1
|
28.7
|
28.9
|
|
29.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
9.5%
|
16.0%
|
15.0 %
|
|
4.0 %
|
10.1%
|
12.2%
|
16.2%
|
|
3.4%
|
|
Average allocated tangible equity (£bn)
|
30.4
|
30.0
|
29.7
|
|
29.6
|
28.6
|
28.7
|
29.6
|
|
29.3
|
|
Income over average risk weighted assets
|
6.1%
|
7.7%
|
8.0%
|
|
5.5%
|
6.3%
|
6.7%
|
7.7%
|
|
5.2%
|
|
Cost: income ratio
|
67%
|
56%
|
53%
|
|
75%
|
65%
|
59%
|
54%
|
|
80%
|
|
Loan loss rate (bps)
|
9
|
13
|
82
|
|
7
|
44
|
21
|
23
|
|
15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Analysis of total income
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
|
FICC
|
1,012
|
1,471
|
1,716
|
|
1,024
|
1,256
|
1,450
|
1,699
|
|
934
|
|
Equities
|
1,010
|
1,261
|
1,116
|
|
703
|
689
|
870
|
963
|
|
604
|
|
Global Markets
|
2,022
|
2,732
|
2,832
|
|
1,727
|
1,945
|
2,320
|
2,662
|
|
1,538
|
|
Advisory
|
222
|
188
|
255
|
|
214
|
196
|
123
|
143
|
|
189
|
|
Equity
capital markets
|
87
|
157
|
92
|
|
56
|
71
|
81
|
70
|
|
98
|
|
Debt
capital markets
|
347
|
402
|
407
|
|
336
|
379
|
364
|
431
|
|
327
|
|
Banking
Fees and Underwriting
|
656
|
747
|
754
|
|
606
|
646
|
568
|
644
|
|
614
|
|
Corporate
lending
|
(13)
|
37
|
16
|
|
27
|
68
|
(4)
|
156
|
|
45
|
|
Transaction
banking
|
464
|
442
|
426
|
|
432
|
424
|
423
|
411
|
|
410
|
|
International
Corporate Banking
|
451
|
479
|
442
|
|
459
|
492
|
419
|
567
|
|
455
|
|
Investment Banking
|
1,107
|
1,226
|
1,196
|
|
1,065
|
1,138
|
987
|
1,211
|
|
1,069
|
|
Total income
|
3,129
|
3,958
|
4,028
|
|
2,792
|
3,083
|
3,307
|
3,873
|
|
2,607
|
|
1
|
Gross loans and advances at amortised cost comprises: loans and
advances to customers and banks at amortised cost, debt securities,
and portfolios reclassified as held for sale, gross of impairment
allowance, and is the denominator used in the LLR
metric.
|
|
Barclays US Consumer
Bank
|
|
|
|
|
|
|
|
|
|
|
|
|
Q326
|
Q226
|
Q126
|
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
|
Income statement information
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
|
Net interest income
|
749
|
732
|
823
|
|
776
|
726
|
640
|
678
|
|
678
|
|
Net fee, commission, trading and other income
|
179
|
404
|
160
|
|
277
|
215
|
183
|
186
|
|
179
|
|
Total income
|
928
|
1,136
|
983
|
|
1,053
|
941
|
823
|
864
|
|
857
|
|
Operating costs
|
(459)
|
(442)
|
(380)
|
|
(427)
|
(407)
|
(396)
|
(407)
|
|
(433)
|
|
UK regulatory levies
|
—
|
—
|
—
|
|
—
|
—
|
—
|
—
|
|
—
|
|
Litigation and conduct
|
(3)
|
(2)
|
—
|
|
(5)
|
—
|
—
|
(3)
|
|
—
|
|
Total operating expenses
|
(462)
|
(444)
|
(380)
|
|
(432)
|
(407)
|
(396)
|
(410)
|
|
(433)
|
|
Other net income
|
—
|
—
|
—
|
|
—
|
—
|
—
|
—
|
|
—
|
|
Profit before impairment
|
466
|
692
|
603
|
|
621
|
534
|
427
|
454
|
|
424
|
|
Credit impairment charges
|
(340)
|
(346)
|
(367)
|
|
(431)
|
(379)
|
(312)
|
(399)
|
|
(298)
|
|
Profit before tax
|
126
|
346
|
236
|
|
190
|
155
|
115
|
55
|
|
126
|
|
Attributable profit
|
92
|
253
|
176
|
|
144
|
118
|
87
|
41
|
|
94
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
|
Gross loans and advances at amortised cost1
|
25.5
|
25.0
|
30.3
|
|
30.6
|
29.8
|
27.4
|
28.9
|
|
30.0
|
|
Loans and advances to customers at amortised cost
|
22.3
|
21.7
|
21.0
|
|
21.1
|
20.0
|
18.2
|
18.8
|
|
20.0
|
|
Deposits at amortised cost
|
25.1
|
24.7
|
25.0
|
|
24.2
|
23.7
|
22.5
|
23.8
|
|
23.3
|
|
Risk weighted assets
|
24.3
|
24.3
|
27.6
|
|
27.4
|
25.8
|
24.7
|
25.6
|
|
26.8
|
|
Period end allocated tangible equity
|
3.3
|
3.4
|
3.8
|
|
3.8
|
3.5
|
3.4
|
3.5
|
|
3.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity2
|
10.9%
|
30.2%
|
18.8%
|
|
15.8%
|
13.5%
|
10.2%
|
4.5%
|
|
11.2%
|
|
Average allocated tangible equity (£bn)
|
3.4
|
3.3
|
3.8
|
|
3.6
|
3.5
|
3.4
|
3.6
|
|
3.4
|
|
Cost: income ratio
|
50%
|
39%
|
39%
|
|
41%
|
43%
|
48%
|
47%
|
|
51%
|
|
Loan loss rate (bps)3
|
529
|
555
|
491
|
|
558
|
505
|
456
|
562
|
|
395
|
|
Net interest margin
|
13.74%
|
13.20%
|
12.76%
|
|
11.63%
|
11.50%
|
10.83%
|
10.53%
|
|
10.66%
|
|
1
|
Gross loans and advances at amortised cost comprises: loans and
advances to customers and banks at amortised cost, debt securities,
and portfolios reclassified as held for sale, gross of impairment
allowance, and is the denominator used in the LLR
metric.
|
|
2
|
Return on average allocated tangible equity, excluding a
c.£225m Q226 gain on sale (recorded in Net fee, commission and
other income) from the AA portfolio exit, was 10.5% for Q226, as a
result of an adjusted attributable profit of
£87m.
|
|
3
|
LLR includes held for sale portfolios to remain consistent with the
treatment of impairment in Q424 to Q126.
|
|
Head Office
|
|
|
|
|
|
|
|
|
|
|
|
|
Q326
|
Q226
|
Q126
|
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
|
Income statement information
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
|
Net interest income
|
35
|
149
|
(53)
|
|
(11)
|
138
|
114
|
174
|
|
183
|
|
Net fee, commission and other income
|
(18)
|
(88)
|
70
|
|
94
|
(105)
|
(43)
|
(109)
|
|
(107)
|
|
Total income
|
17
|
61
|
17
|
|
83
|
33
|
71
|
65
|
|
76
|
|
Operating costs
|
(204)
|
(163)
|
(205)
|
|
(203)
|
(162)
|
(175)
|
(207)
|
|
(233)
|
|
UK regulatory levies
|
—
|
—
|
—
|
|
(8)
|
—
|
—
|
—
|
|
(9)
|
|
Litigation and conduct
|
7
|
(1)
|
(107)
|
|
(13)
|
(239)
|
(2)
|
(3)
|
|
(84)
|
|
Total operating expenses
|
(197)
|
(164)
|
(312)
|
|
(224)
|
(401)
|
(177)
|
(210)
|
|
(326)
|
|
Other net income/(expenses)
|
20
|
3
|
21
|
|
(25)
|
39
|
(9)
|
18
|
|
—
|
|
(Loss)/profit before impairment
|
(160)
|
(100)
|
(274)
|
|
(166)
|
(329)
|
(115)
|
(127)
|
|
(250)
|
|
Credit impairment releases/(charges)
|
—
|
—
|
2
|
|
(5)
|
(1)
|
(1)
|
(4)
|
|
(42)
|
|
Loss before tax
|
(160)
|
(100)
|
(272)
|
|
(171)
|
(330)
|
(116)
|
(131)
|
|
(292)
|
|
Attributable loss
|
(118)
|
(97)
|
(206)
|
|
(152)
|
(299)
|
(114)
|
(124)
|
|
(318)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
|
Risk weighted assets
|
13.2
|
12.7
|
12.3
|
|
12.3
|
12.7
|
12.6
|
12.7
|
|
16.2
|
|
Period end allocated tangible equity
|
4.0
|
6.5
|
5.4
|
|
7.5
|
5.8
|
5.9
|
4.7
|
|
2.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance measures
|
|
|
|
|
|
|
|
|
|
|
|
Average allocated tangible equity (£bn)
|
5.1
|
5.6
|
6.8
|
|
6.7
|
6.6
|
5.5
|
3.8
|
|
3.4
|
Performance
Management
|
Margins and
balances
|
|
|
|
|
|
|
|
|
Nine months ended 30.09.26
|
Nine months ended 30.09.25
|
||||
|
|
Net interest income
|
Average customer assets
|
Net interest margin
|
Net interest income
|
Average customer assets
|
Net interest margin
|
|
|
£m
|
£m
|
%
|
£m
|
£m
|
%
|
|
Barclays UK
|
6,059
|
219,112
|
3.70
|
5,638
|
209,779
|
3.59
|
|
Barclays UK Corporate Bank
|
1,244
|
29,460
|
5.65
|
1,084
|
25,584
|
5.66
|
|
Barclays Private Bank and Wealth Management
|
643
|
15,193
|
5.66
|
597
|
14,735
|
5.42
|
|
Barclays US Consumer Bank
|
2,304
|
23,344
|
13.20
|
2,044
|
24,930
|
10.96
|
|
Group excluding IB and Head Office
|
10,250
|
287,109
|
4.77
|
9,363
|
275,028
|
4.55
|
|
Barclays Investment Bank
|
1,187
|
|
|
978
|
|
|
|
Head Office
|
131
|
|
|
426
|
|
|
|
Barclays Group Net interest income
|
11,568
|
|
|
10,767
|
|
|
The Group excluding IB and Head Office net interest margin
increased by 22bps from 4.55% in Q325 to 4.77% in Q326 due to Group
structural hedge income, partner reward updates and changes in
portfolio mix in USCB.
|
Quarterly analysis
|
|
|
|||
|
|
Q326
|
Q226
|
Q126
|
Q425
|
Q325
|
|
Net interest income
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
Barclays UK
|
2,073
|
2,000
|
1,986
|
2,015
|
1,961
|
|
Barclays UK Corporate Bank
|
437
|
413
|
394
|
396
|
383
|
|
Barclays Private Bank and Wealth Management
|
223
|
216
|
204
|
202
|
190
|
|
Barclays US Consumer Bank
|
749
|
732
|
823
|
776
|
726
|
|
Group excluding IB and Head Office
|
3,482
|
3,361
|
3,407
|
3,389
|
3,260
|
|
|
|
|
|
|
|
|
Average customer assets
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
Barclays UK
|
222,936
|
217,778
|
216,623
|
214,770
|
211,384
|
|
Barclays UK Corporate Bank
|
30,224
|
29,603
|
28,536
|
27,841
|
26,645
|
|
Barclays Private Bank and Wealth Management
|
15,620
|
14,936
|
15,022
|
15,105
|
14,802
|
|
Barclays US Consumer Bank
|
21,624
|
22,247
|
26,163
|
26,470
|
25,037
|
|
Group excluding IB and Head Office
|
290,404
|
284,564
|
286,344
|
284,186
|
277,868
|
|
|
|
|
|
|
|
|
Net interest margin
|
%
|
%
|
%
|
%
|
%
|
|
Barclays UK
|
3.69
|
3.68
|
3.72
|
3.72
|
3.68
|
|
Barclays UK Corporate Bank
|
5.74
|
5.60
|
5.60
|
5.64
|
5.70
|
|
Barclays Private Bank and Wealth Management
|
5.66
|
5.80
|
5.51
|
5.31
|
5.09
|
|
Barclays US Consumer Bank
|
13.74
|
13.20
|
12.76
|
11.63
|
11.50
|
|
Group excluding IB and Head Office
|
4.76
|
4.74
|
4.83
|
4.73
|
4.65
|
Structural hedge
The Group employs a structural hedge programme designed to
stabilise NIM on fixed rate non-maturity balance sheet items that
are behaviourally stable. As interest rates move, such balances
would otherwise drive material income volatility where there is a
re-pricing mismatch with floating rate assets.
The structural hedge predominantly covers non-interest-bearing
current accounts and the fixed portion of instant access savings
accounts as well as equity, which are invested into either floating
rate customer assets or balances at central banks, creating an
exposure to changes in interest rates. The structural hedge is
executed primarily via a portfolio of receive-fixed, pay variable
interest rate swaps, with an amortising structure so that a small
portion matures and is reinvested each month at prevailing market
rates. The pay-floating leg of the interest rate swaps nets down a
proportion of the receive-floating income from the customer assets,
leaving a receive-fixed income stream from the structural
hedge.
The purpose of the structural hedge is to smooth the Group NII
through time. The floating leg of the swap will re-price
immediately, whereas the fixed rate yield on the portfolio reprices
gradually, as a portion of the swap portfolio matures and the roll
is re-invested onto new market rates.
When interest rates are higher than our structural hedge yield, the
pay-floating rate will typically be higher than our average
receive-fixed rate. In this scenario, when viewed in isolation, the
structural hedge will be a net drag to Group NII. When floating
rates are lower than our structural hedge yield, the hedge in
isolation will be a net benefit.
Since the receive-fixed swaps are booked for a specific term, an
element of NII is ‘locked in’. The income stabilising
feature of the structural hedge provides greater net interest
income certainty through the interest rate cycle.
The structural hedge is one component of a larger portfolio of
interest rate risk management activities that includes
non-structural hedging (e.g. pay-fixed and receive-variable flows
for asset hedging), and other offsetting flows. The net risk of
these positions is executed externally through interest rate swaps
and managed for accounting risk (i.e. income volatility arising
from the accounting mismatch of swaps at fair value through profit
and loss and underlying hedged items at amortised cost) within the
cash flow hedging reserve.
Overall the Group has external derivatives designated as cash flow
hedges that hedge interest rate risk with a notional of
£122.2bn (December 2025: £114.6bn) which reflects the
structural hedge derivatives notional of £240.6bn (December
2025: £236.1bn) netted with non-structural hedging positions
of £118.4bn (December 2025: £121.5bn). The majority of
these interest rate swaps are cleared with Central Clearing
Counterparties and margined daily with an average structural hedge
duration of c.3.5 years.
Gross structural hedge contributions were £5,352m (September
2025: £4,313m). Gross structural hedge contributions primarily
represent the absolute interest income earned on the fixed legs of
the swaps in the structural hedge as the floating leg is offset by
the base rate funding of the deposits.
Credit
Risk
Loans and advances at amortised cost
by geography
Total loans and advances at amortised cost in the credit risk
section includes loans and advances at amortised cost to banks and
loans and advances at amortised cost to customers.
The table below presents a product and geographical breakdown of
loans and advances at amortised cost and the impairment allowance
by stage. The table also presents stage allocation of debt
securities and off-balance sheet loan commitments and financial
guarantee contracts.
The impairment allowance under IFRS 9 considers both the drawn and
the undrawn counterparty exposure. For retail portfolios, the total
impairment allowance is allocated to gross loans and advances to
the extent allowance does not exceed the drawn exposure and any
excess is reported on the liabilities side of the balance sheet as
a provision. For wholesale portfolios, impairment allowance on
undrawn exposure is reported on the liability side of the balance
sheet as a provision.
|
|
Gross exposure
|
|
Impairment allowance
|
||||||
|
|
Stage 1
|
Stage 2
|
Stage 35
|
Total
|
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
|
As at 30.09.26
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
Retail mortgages
|
168,607
|
13,370
|
1,797
|
183,774
|
|
18
|
20
|
62
|
100
|
|
Retail credit cards
|
15,336
|
2,231
|
245
|
17,812
|
|
161
|
457
|
155
|
773
|
|
Retail other
|
9,209
|
1,705
|
223
|
11,137
|
|
106
|
183
|
181
|
470
|
|
Corporate loans1
|
56,882
|
6,394
|
1,624
|
64,900
|
|
93
|
170
|
549
|
812
|
|
Total UK
|
250,034
|
23,700
|
3,889
|
277,623
|
|
378
|
830
|
947
|
2,155
|
|
Retail mortgages
|
1,649
|
264
|
161
|
2,074
|
|
3
|
1
|
25
|
29
|
|
Retail credit cards
|
19,282
|
2,883
|
1,779
|
23,944
|
|
400
|
815
|
1,418
|
2,633
|
|
Retail other
|
4,219
|
350
|
70
|
4,639
|
|
16
|
8
|
18
|
42
|
|
Corporate loans
|
75,248
|
3,615
|
1,892
|
80,755
|
|
76
|
133
|
292
|
501
|
|
Total Rest of the World
|
100,398
|
7,112
|
3,902
|
111,412
|
|
495
|
957
|
1,753
|
3,205
|
|
Total loans and advances at amortised cost
|
350,432
|
30,812
|
7,791
|
389,035
|
|
873
|
1,787
|
2,700
|
5,360
|
|
Debt securities at amortised cost
|
69,553
|
1,255
|
—
|
70,808
|
|
11
|
10
|
—
|
21
|
|
Total loans and advances at amortised cost including debt
securities
|
419,985
|
32,067
|
7,791
|
459,843
|
|
884
|
1,797
|
2,700
|
5,381
|
|
Off-balance sheet loan commitments and financial guarantee
contracts2
|
403,993
|
16,478
|
1,166
|
421,637
|
|
155
|
225
|
33
|
413
|
|
Total3,4
|
823,978
|
48,545
|
8,957
|
881,480
|
|
1,039
|
2,022
|
2,733
|
5,794
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net exposure
|
|
Coverage ratio
|
||||||
|
|
Stage 1
|
Stage 2
|
Stage 35
|
Total
|
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
|
As at 30.09.26
|
£m
|
£m
|
£m
|
£m
|
|
%
|
%
|
%
|
%
|
|
Retail mortgages
|
168,589
|
13,350
|
1,735
|
183,674
|
|
—
|
0.1
|
3.5
|
0.1
|
|
Retail credit cards
|
15,175
|
1,774
|
90
|
17,039
|
|
1.0
|
20.5
|
63.3
|
4.3
|
|
Retail other
|
9,103
|
1,522
|
42
|
10,667
|
|
1.2
|
10.7
|
81.2
|
4.2
|
|
Corporate loans1
|
56,789
|
6,224
|
1,075
|
64,088
|
|
0.2
|
2.7
|
33.8
|
1.3
|
|
Total UK
|
249,656
|
22,870
|
2,942
|
275,468
|
|
0.2
|
3.5
|
24.4
|
0.8
|
|
Retail mortgages
|
1,646
|
263
|
136
|
2,045
|
|
0.2
|
0.4
|
15.5
|
1.4
|
|
Retail credit cards
|
18,882
|
2,068
|
361
|
21,311
|
|
2.1
|
28.3
|
79.7
|
11.0
|
|
Retail other
|
4,203
|
342
|
52
|
4,597
|
|
0.4
|
2.3
|
25.7
|
0.9
|
|
Corporate loans
|
75,172
|
3,482
|
1,600
|
80,254
|
|
0.1
|
3.7
|
15.4
|
0.6
|
|
Total Rest of the World
|
99,903
|
6,155
|
2,149
|
108,207
|
|
0.5
|
13.5
|
44.9
|
2.9
|
|
Total loans and advances at amortised cost
|
349,559
|
29,025
|
5,091
|
383,675
|
|
0.2
|
5.8
|
34.7
|
1.4
|
|
Debt securities at amortised cost
|
69,542
|
1,245
|
—
|
70,787
|
|
—
|
0.8
|
—
|
—
|
|
Total loans and advances at amortised cost including debt
securities
|
419,101
|
30,270
|
5,091
|
454,462
|
|
0.2
|
5.6
|
34.7
|
1.2
|
|
Off-balance sheet loan commitments and financial guarantee
contracts2
|
403,838
|
16,253
|
1,133
|
421,224
|
|
—
|
1.4
|
2.8
|
0.1
|
|
Total3,4
|
822,939
|
46,523
|
6,224
|
875,686
|
|
0.1
|
4.2
|
30.5
|
0.7
|
|
1
|
Includes Business Banking, which has a gross exposure of
£12.5bn and an impairment allowance of £280m. This
comprises £34m impairment allowance on £10.1bn Stage 1
exposure, £59m on £1.7bn Stage 2 exposure and £187m
on £0.7bn Stage 3 exposure. Excluding this, total coverage for
corporate loans in UK is 1.0%.
|
|
2
|
Excludes loan commitments and financial guarantees of £37.7bn
carried at fair value.
|
|
3
|
Excludes other financial assets subject to impairment comprising of
cash collateral and settlement balances, reverse repurchase
agreements and other similar secured lending, financial assets at
fair value through other comprehensive income and other assets.
These have a total gross exposure of £275.0bn and an
impairment allowance of £149m. This comprises £20m
impairment allowance on £274.6bn Stage 1 exposure, £8m on
£0.4bn Stage 2 exposure and £121m on £128m Stage 3
exposure.
|
|
4
|
The annualised loan loss rate is 55bps after applying the total
impairment charges of £1,897m.
|
|
5
|
Purchased or originated credit-impaired (POCI) balances are no
longer presented following the sale of those balances as part of
the Tesco debt sale completed in September 2026. The corresponding
FY25 balances of £44m are included within Stage 3 exposure as
at 31.12.25.
|
|
|
Gross exposure
|
|
Impairment allowance
|
||||||
|
|
Stage 1
|
Stage 2
|
Stage 35
|
Total
|
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
|
As at 31.12.25
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
Retail mortgages
|
159,825
|
13,757
|
1,836
|
175,418
|
|
15
|
16
|
60
|
91
|
|
Retail credit cards
|
14,922
|
1,943
|
303
|
17,168
|
|
171
|
398
|
174
|
743
|
|
Retail other
|
9,867
|
1,512
|
301
|
11,680
|
|
98
|
178
|
214
|
490
|
|
Corporate loans1
|
54,182
|
6,936
|
1,392
|
62,510
|
|
125
|
180
|
422
|
727
|
|
Total UK
|
238,796
|
24,148
|
3,832
|
266,776
|
|
409
|
772
|
870
|
2,051
|
|
Retail mortgages
|
1,829
|
72
|
131
|
2,032
|
|
2
|
—
|
24
|
26
|
|
Retail credit cards
|
18,801
|
2,536
|
1,776
|
23,113
|
|
395
|
796
|
1,395
|
2,586
|
|
Retail other
|
2,482
|
206
|
63
|
2,751
|
|
3
|
5
|
19
|
27
|
|
Corporate loans
|
66,671
|
3,702
|
1,767
|
72,140
|
|
82
|
135
|
382
|
599
|
|
Total Rest of the World
|
89,783
|
6,516
|
3,737
|
100,036
|
|
482
|
936
|
1,820
|
3,238
|
|
Total loans and advances at amortised cost
|
328,579
|
30,664
|
7,569
|
366,812
|
|
891
|
1,708
|
2,690
|
5,289
|
|
Debt securities at amortised cost
|
68,126
|
371
|
—
|
68,497
|
|
13
|
9
|
—
|
22
|
|
Total loans and advances at amortised cost including debt
securities
|
396,705
|
31,035
|
7,569
|
435,309
|
|
904
|
1,717
|
2,690
|
5,311
|
|
Off-balance sheet loan commitments and financial guarantee
contracts2
|
410,493
|
16,473
|
817
|
427,783
|
|
144
|
240
|
32
|
416
|
|
Total3,4
|
807,198
|
47,508
|
8,386
|
863,092
|
|
1,048
|
1,957
|
2,722
|
5,727
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net exposure
|
|
Coverage ratio
|
||||||
|
|
Stage 1
|
Stage 2
|
Stage 35
|
Total
|
|
Stage 1
|
Stage 2
|
Stage 3
|
Total
|
|
As at 31.12.25
|
£m
|
£m
|
£m
|
£m
|
|
%
|
%
|
%
|
%
|
|
Retail mortgages
|
159,810
|
13,741
|
1,776
|
175,327
|
|
—
|
0.1
|
3.3
|
0.1
|
|
Retail credit cards
|
14,751
|
1,545
|
129
|
16,425
|
|
1.1
|
20.5
|
57.4
|
4.3
|
|
Retail other
|
9,769
|
1,334
|
87
|
11,190
|
|
1.0
|
11.8
|
71.1
|
4.2
|
|
Corporate loans1
|
54,057
|
6,756
|
970
|
61,783
|
|
0.2
|
2.6
|
30.3
|
1.2
|
|
Total UK
|
238,387
|
23,376
|
2,962
|
264,725
|
|
0.2
|
3.2
|
22.7
|
0.8
|
|
Retail mortgages
|
1,827
|
72
|
107
|
2,006
|
|
0.1
|
—
|
18.3
|
1.3
|
|
Retail credit cards
|
18,406
|
1,740
|
381
|
20,527
|
|
2.1
|
31.4
|
78.5
|
11.2
|
|
Retail other
|
2,479
|
201
|
44
|
2,724
|
|
0.1
|
2.4
|
30.2
|
1.0
|
|
Corporate loans
|
66,589
|
3,567
|
1,385
|
71,541
|
|
0.1
|
3.6
|
21.6
|
0.8
|
|
Total Rest of the World
|
89,301
|
5,580
|
1,917
|
96,798
|
|
0.5
|
14.4
|
48.7
|
3.2
|
|
Total loans and advances at amortised cost
|
327,688
|
28,956
|
4,879
|
361,523
|
|
0.3
|
5.6
|
35.5
|
1.4
|
|
Debt securities at amortised cost
|
68,113
|
362
|
—
|
68,475
|
|
—
|
2.4
|
—
|
—
|
|
Total loans and advances at amortised cost including debt
securities
|
395,801
|
29,318
|
4,879
|
429,998
|
|
0.2
|
5.5
|
35.5
|
1.2
|
|
Off-balance sheet loan commitments and financial guarantee
contracts2
|
410,349
|
16,233
|
785
|
427,367
|
|
—
|
1.5
|
3.9
|
0.1
|
|
Total3,4
|
806,150
|
45,551
|
5,664
|
857,365
|
|
0.1
|
4.1
|
32.5
|
0.7
|
|
1
|
Includes Business Banking, which has a gross exposure of
£12.4bn and an impairment allowance of £326m. This
comprises £62m impairment allowance on £9.3bn Stage 1
exposure, £50m on £2.3bn Stage 2 exposure and £214m
on £0.8bn Stage 3 exposure. Excluding this, total coverage for
corporate loans in UK is 0.8%.
|
|
2
|
Excludes loan commitments and financial guarantees of £22.2bn
carried at fair value and includes exposure relating to financial
assets classified as assets held for sale.
|
|
3
|
Excludes other financial assets subject to impairment comprising of
cash collateral and settlement balances, reverse repurchase
agreements and other similar secured lending, financial assets at
fair value through other comprehensive income and other assets.
These have a total gross exposure of £224.1bn and an
impairment allowance of £150m. This comprises £18m
impairment allowance on £222.4bn Stage 1 exposure, £8m on
£1.6bn Stage 2 exposure and £124m on £127m Stage 3
exposure.
|
|
4
|
The annualised loan loss rate is 52bps after applying the total
impairment charges of £2,279m.
|
|
5
|
POCI balances are no longer presented following the sale of those
balances as part of the Tesco debt sale completed in September
2026. The corresponding FY25 balances of £44m are included
within Stage 3 exposure as at 31.12.25.
|
Assets held for
sale
The prior period presents gross loans and advances and the related
impairment allowance for the AA portfolio in USCB classified as
assets held for sale in the condensed consolidated balance sheet.
The sale of this portfolio was completed on 24 April
2026.
|
Loans and advances by
product
|
|||||||||||||||
|
|
Stage 1
|
|
Stage 2
|
|
Stage 3
|
|
Total
|
||||||||
|
|
Gross
|
ECL
|
Coverage
|
|
Gross
|
ECL
|
Coverage
|
|
Gross
|
ECL
|
Coverage
|
|
Gross
|
ECL
|
Coverage
|
|
As at 31.12.25
|
£m
|
£m
|
%
|
|
£m
|
£m
|
%
|
|
£m
|
£m
|
%
|
|
£m
|
£m
|
%
|
|
Retail credit cards - US
|
5,468
|
65
|
1.2
|
|
466
|
124
|
26.6
|
|
54
|
44
|
81.5
|
|
5,988
|
233
|
3.9
|
|
Corporate loans - US
|
43
|
1
|
2.3
|
|
6
|
2
|
33.3
|
|
—
|
—
|
—
|
|
49
|
3
|
6.1
|
|
Total Rest of the World
|
5,511
|
66
|
1.2
|
|
472
|
126
|
26.7
|
|
54
|
44
|
81.5
|
|
6,037
|
236
|
3.9
|
Loans and advances at amortised cost
by product
The table below presents loans and advances at amortised cost by
product and stage, including Stage 2 past due
balances.
|
|
|
Stage 2
|
|
|
|||
|
As at 30.09.26
|
Stage 1
|
Not past due
|
<=30 days past due
|
>30 days past due
|
Total
|
Stage 31
|
Total
|
|
Gross exposure
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
Retail mortgages
|
170,256
|
10,931
|
2,006
|
697
|
13,634
|
1,958
|
185,848
|
|
Retail credit cards
|
34,618
|
4,466
|
345
|
303
|
5,114
|
2,024
|
41,756
|
|
Retail other
|
13,428
|
1,782
|
191
|
82
|
2,055
|
293
|
15,776
|
|
Corporate loans
|
132,130
|
9,781
|
155
|
73
|
10,009
|
3,516
|
145,655
|
|
Total
|
350,432
|
26,960
|
2,697
|
1,155
|
30,812
|
7,791
|
389,035
|
|
|
|
|
|
|
|
|
|
|
Impairment allowance
|
|
|
|
|
|
|
|
|
Retail mortgages
|
21
|
12
|
6
|
3
|
21
|
87
|
129
|
|
Retail credit cards
|
561
|
932
|
145
|
195
|
1,272
|
1,573
|
3,406
|
|
Retail other
|
122
|
124
|
33
|
34
|
191
|
199
|
512
|
|
Corporate loans
|
169
|
282
|
10
|
11
|
303
|
841
|
1,313
|
|
Total
|
873
|
1,350
|
194
|
243
|
1,787
|
2,700
|
5,360
|
|
|
|
|
|
|
|
|
|
|
Net exposure
|
|
|
|
|
|
|
|
|
Retail mortgages
|
170,235
|
10,919
|
2,000
|
694
|
13,613
|
1,871
|
185,719
|
|
Retail credit cards
|
34,057
|
3,534
|
200
|
108
|
3,842
|
451
|
38,350
|
|
Retail other
|
13,306
|
1,658
|
158
|
48
|
1,864
|
94
|
15,264
|
|
Corporate loans
|
131,961
|
9,499
|
145
|
62
|
9,706
|
2,675
|
144,342
|
|
Total
|
349,559
|
25,610
|
2,503
|
912
|
29,025
|
5,091
|
383,675
|
|
|
|
|
|
|
|
|
|
|
Coverage ratio
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
|
Retail mortgages
|
—
|
0.1
|
0.3
|
0.4
|
0.2
|
4.4
|
0.1
|
|
Retail credit cards
|
1.6
|
20.9
|
42.0
|
64.4
|
24.9
|
77.7
|
8.2
|
|
Retail other
|
0.9
|
7.0
|
17.3
|
41.5
|
9.3
|
67.9
|
3.2
|
|
Corporate loans
|
0.1
|
2.9
|
6.5
|
15.1
|
3.0
|
23.9
|
0.9
|
|
Total
|
0.2
|
5.0
|
7.2
|
21.0
|
5.8
|
34.7
|
1.4
|
|
As at 31.12.25
|
|
|
|
|
|
|
|
|
Gross exposure
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
Retail mortgages
|
161,65
|
11,072
|
2,033
|
724
|
13,829
|
1,967
|
177,450
|
|
Retail credit cards
|
33,723
|
3,832
|
317
|
330
|
4,479
|
2,079
|
40,281
|
|
Retail other
|
12,349
|
1,398
|
207
|
113
|
1,718
|
364
|
14,431
|
|
Corporate loans
|
120,853
|
10,409
|
71
|
158
|
10,638
|
3,159
|
134,650
|
|
Total
|
328,579
|
26,711
|
2,628
|
1,325
|
30,664
|
7,569
|
366,812
|
|
|
|
|
|
|
|
|
|
|
Impairment allowance
|
|
|
|
|
|
|
|
|
Retail mortgages
|
17
|
9
|
4
|
3
|
16
|
84
|
117
|
|
Retail credit cards
|
566
|
840
|
138
|
216
|
1,194
|
1,569
|
3,329
|
|
Retail other
|
101
|
126
|
28
|
29
|
183
|
233
|
517
|
|
Corporate loans
|
207
|
298
|
7
|
10
|
315
|
804
|
1,326
|
|
Total
|
891
|
1,273
|
177
|
258
|
1,708
|
2,690
|
5,289
|
|
|
|
|
|
|
|
|
|
|
Net exposure
|
|
|
|
|
|
|
|
|
Retail mortgages
|
161,637
|
11,063
|
2,029
|
721
|
13,813
|
1,883
|
177,333
|
|
Retail credit cards
|
33,157
|
2,992
|
179
|
114
|
3,285
|
510
|
36,952
|
|
Retail other
|
12,248
|
1,272
|
179
|
84
|
1,535
|
131
|
13,914
|
|
Corporate loans
|
120,646
|
10,111
|
64
|
148
|
10,323
|
2,355
|
133,324
|
|
Total
|
327,688
|
25,438
|
2,451
|
1,067
|
28,956
|
4,879
|
361,523
|
|
|
|
|
|
|
|
|
|
|
Coverage ratio
|
%
|
%
|
%
|
%
|
%
|
%
|
%
|
|
Retail mortgages
|
—
|
0.1
|
0.2
|
0.4
|
0.1
|
4.3
|
0.1
|
|
Retail credit cards
|
1.7
|
21.9
|
43.5
|
65.5
|
26.7
|
75.5
|
8.3
|
|
Retail other
|
0.8
|
9.0
|
13.5
|
25.7
|
10.7
|
64.0
|
3.6
|
|
Corporate loans
|
0.2
|
2.9
|
9.9
|
6.3
|
3.0
|
25.5
|
1.0
|
|
Total
|
0.3
|
4.8
|
6.7
|
19.5
|
5.6
|
35.5
|
1.4
|
|
1
|
POCI balances are no longer presented following the sale of those
balances as part of the Tesco debt sale completed in September
2026. The corresponding FY25 balances of £44m are included
within Stage 3 exposure as at 31.12.25.
|
Measurement
uncertainty
Scenarios used to calculate the Group’s modelled ECL charge
were refreshed in Q326, with the Baseline scenario reflecting the
latest consensus macroeconomic forecasts available at the time of
the scenario refresh. The Baseline scenario continues to reflect
the volatile trade policies of the US administration and ongoing
geopolitical uncertainty, compounded by ongoing tensions in the
Middle East and associated risks to global energy markets.
Global growth slows modestly as higher US tariffs, retaliatory
measures and persistent uncertainty disrupt trade flows, weigh on
investment and dampen business confidence, though domestic demand
in advanced economies remains relatively resilient. UK and US GDP
growth in 2027 is expected to be 1.2% and 2.1%, respectively.
Inflationary pressures remain elevated, with some tariff
pass-through, higher energy prices, renewed supply-side frictions
and increased transportation costs contributing to a more
persistent and broad-based inflation profile. The softening in
labour markets is gradual and insufficient to quickly alleviate
underlying price pressures. UK and US quarterly unemployment rates
peak at 5.2% and 4.3%, respectively.
The Downside scenarios have been calibrated to capture a severe
escalation in geopolitical tensions, centred on a prolonged Middle
East conflict, alongside intensifying global trade frictions. Early
in the scenario, conflict escalates sharply with disruptions at
critical maritime chokepoints, triggering severe shipping
disruptions, surging insurance costs and sharp increases in oil and
gas prices amid infrastructure damage. As the shock becomes
protracted, firms delay investment, reassess supply chains and
hoard inputs, while business and consumer confidence fall sharply.
In Downside 2, UK and US GDP in 2027 falls by 3.9% and 3.8%,
respectively. Inflation dynamics diverge sharply from Baseline,
generating a stagflationary impulse. The deterioration in demand
and investment drives a sharp increase in unemployment, initially
concentrated in trade and energy exposed sectors but increasingly
spilling over into services. In Downside 2, UK and US quarterly
unemployment rates peak at 8.1% and 8.8%, respectively.
Monetary policy faces a difficult trade-off between persistent
inflation and weakening growth. Central banks initially hike rates
to ensure inflation expectations remain well anchored, but as the
downturn deepens and demand forces weaken price pressures, they
shift towards easing. The scenarios also incorporate
climate-related risks through both physical and transition
channels, including more frequent severe weather disruptions and a
shift in sentiment around energy security. These effects amplify
volatility, increase costs and further weigh on growth over the
medium term.
In the Upside scenarios, a rise in labour force participation and
higher productivity contribute to accelerated economic growth,
without creating new inflationary pressures. Central banks lower
interest rates stimulating private consumption and investment
growth. Demand for labour increases and unemployment decreases. As
geopolitical tensions ease, low inflation supports consumer
purchasing power and contributes further to healthy GDP growth. The
strong economic outlook and lower interest rates provide a boost to
house price growth.
The methodology for estimating scenario weights involves simulating
a range of future paths for UK and US GDP using historical data
with the five scenarios mapped against the distribution of these
future paths. The increase in the Upside weights and the reduction
in the Baseline and Downside weights in Q326 was driven by
improvement in UK and US GDP outlook in the Baseline scenario,
moving the Baseline scenario closer to the Upside scenarios. For
further details see page 44
However, the Group expects geopolitical uncertainty to remain
elevated and any potential impact on corporate earnings is expected
to lag. In response, the £66m¹ management adjustment
introduced in Q126 within the Investment Bank has been
retained.
The following tables show the key macroeconomic variables used in
the five scenarios (5-year annual paths) and the weights applied to
each scenario.
|
1
|
Excludes management adjustment of £2m related to other
financial assets subject to impairment.
|
|
Macroeconomic variables used in the
calculation of ECL
|
|||||
|
As at 30.09.26
|
2026
|
2027
|
2028
|
2029
|
2030
|
|
Baseline
|
%
|
%
|
%
|
%
|
%
|
|
UK GDP1
|
1.3
|
1.2
|
1.6
|
1.7
|
1.7
|
|
UK unemployment2
|
5.1
|
5.1
|
5.2
|
4.9
|
4.7
|
|
UK HPI3
|
1.6
|
2.0
|
3.2
|
5.0
|
4.5
|
|
UK bank rate4
|
3.8
|
4.3
|
4.3
|
4.3
|
4.3
|
|
UK CPI5
|
3.2
|
2.1
|
1.4
|
2.4
|
1.8
|
|
US GDP1
|
2.2
|
2.1
|
2.2
|
2.2
|
2.2
|
|
US unemployment6
|
4.3
|
4.3
|
4.2
|
4.2
|
4.2
|
|
US HPI7
|
1.7
|
1.0
|
1.7
|
1.7
|
1.7
|
|
US federal funds rate4
|
3.8
|
4.0
|
4.0
|
4.0
|
4.0
|
|
US CPI8
|
3.3
|
2.3
|
2.2
|
2.3
|
2.2
|
|
|
|
|
|
|
|
|
Downside 2
|
|
|
|
|
|
|
UK GDP1
|
1.1
|
(3.9)
|
0.3
|
2.3
|
1.0
|
|
UK unemployment2
|
5.4
|
7.6
|
7.9
|
7.1
|
6.2
|
|
UK HPI3
|
(4.2)
|
(25.4)
|
3.1
|
10.4
|
5.6
|
|
UK bank rate4
|
3.9
|
5.1
|
4.7
|
4.5
|
4.5
|
|
UK CPI5
|
5.1
|
6.7
|
1.0
|
0.5
|
1.1
|
|
US GDP1
|
1.9
|
(3.8)
|
(1.1)
|
1.8
|
2.0
|
|
US unemployment6
|
4.8
|
8.1
|
8.5
|
7.5
|
6.4
|
|
US HPI7
|
(0.1)
|
(10.2)
|
3.8
|
6.3
|
3.0
|
|
US federal funds rate4
|
3.8
|
4.8
|
4.4
|
4.3
|
4.3
|
|
US CPI8
|
4.6
|
5.5
|
1.8
|
1.8
|
2.0
|
|
|
|
|
|
|
|
|
Downside 1
|
|
|
|
|
|
|
UK GDP1
|
1.2
|
(1.3)
|
1.0
|
2.0
|
1.4
|
|
UK unemployment2
|
5.2
|
6.4
|
6.6
|
6.0
|
5.5
|
|
UK HPI3
|
(1.3)
|
(12.4)
|
3.2
|
7.7
|
5.0
|
|
UK bank rate4
|
3.9
|
4.7
|
4.5
|
4.4
|
4.4
|
|
UK CPI5
|
4.1
|
4.3
|
1.2
|
1.5
|
1.5
|
|
US GDP1
|
2.0
|
(0.9)
|
0.5
|
2.0
|
2.1
|
|
US unemployment6
|
4.6
|
6.2
|
6.4
|
5.8
|
5.3
|
|
US HPI7
|
0.8
|
(4.7)
|
2.7
|
4.0
|
2.3
|
|
US federal funds rate4
|
3.8
|
4.5
|
4.3
|
4.3
|
4.3
|
|
US CPI8
|
3.9
|
3.9
|
2.0
|
2.1
|
2.1
|
|
|
|
|
|
|
|
|
Upside 2
|
|
|
|
|
|
|
UK GDP1
|
1.5
|
3.5
|
3.4
|
2.8
|
2.4
|
|
UK unemployment2
|
5.0
|
4.5
|
4.4
|
4.0
|
3.8
|
|
UK HPI3
|
1.9
|
14.0
|
6.9
|
4.0
|
4.2
|
|
UK bank rate4
|
3.8
|
3.8
|
3.1
|
3.1
|
3.3
|
|
UK CPI5
|
2.7
|
1.2
|
1.2
|
1.3
|
1.2
|
|
US GDP1
|
2.2
|
3.0
|
3.0
|
2.8
|
2.8
|
|
US unemployment6
|
4.2
|
3.6
|
3.5
|
3.5
|
3.5
|
|
US HPI7
|
3.9
|
4.7
|
5.2
|
4.8
|
4.8
|
|
US federal funds rate4
|
3.7
|
3.3
|
3.3
|
3.3
|
3.1
|
|
US CPI8
|
2.8
|
1.6
|
1.6
|
1.6
|
1.6
|
|
1Average Real GDP seasonally adjusted change in year.2Average
UK unemployment rate 16-year+.3Change in year-end UK HPI = Halifax
HPI Meth2 All Houses, All Buyers index, relative to prior
year-end.4Average rate.5Change in year-end UK CPI = Harmonised
Index of Consumer Prices, relative to prior year-end.6Average US
civilian unemployment rate 16-year+.7Change in year-end US HPI =
FHFA House Price Index, relative to prior year-end.8Change in
year-end US CPI = Consumer Price Index, relative to prior
year-end.
|
|||||
|
Upside 1
|
|
|
|
|
|
|
UK GDP1
|
1.4
|
2.3
|
2.5
|
2.2
|
2.0
|
|
UK unemployment2
|
5.1
|
4.8
|
4.8
|
4.5
|
4.3
|
|
UK HPI3
|
1.7
|
7.9
|
5.1
|
4.5
|
4.3
|
|
UK bank rate4
|
3.8
|
4.0
|
3.7
|
3.7
|
3.8
|
|
UK CPI5
|
3.0
|
1.6
|
1.3
|
1.8
|
1.5
|
|
US GDP1
|
2.2
|
2.6
|
2.6
|
2.5
|
2.5
|
|
US unemployment6
|
4.3
|
4.0
|
3.9
|
3.9
|
3.9
|
|
US HPI7
|
2.8
|
2.8
|
3.4
|
3.2
|
3.2
|
|
US federal funds rate4
|
3.8
|
3.8
|
3.8
|
3.8
|
3.6
|
|
US CPI8
|
3.0
|
1.9
|
1.9
|
2.0
|
1.9
|
|
1
|
Average Real GDP seasonally adjusted change in year.
|
|
2
|
Average UK unemployment rate 16-year+.
|
|
3
|
Change in year-end UK HPI = Halifax HPI Meth2 All Houses, All
Buyers index, relative to prior year-end.
|
|
4
|
Average rate.
|
|
5
|
Change in year-end UK CPI = Harmonised Index of Consumer Prices,
relative to prior year-end.
|
|
6
|
Average US civilian unemployment rate 16-year+.
|
|
7
|
Change in year-end US HPI = FHFA House Price Index, relative to
prior year-end.
|
|
8
|
Change in year-end US CPI = Consumer Price Index, relative to prior
year-end.
|
|
Macroeconomic variables used in the
calculation of ECL
|
|||||
|
As at 30.06.26
|
2026
|
2027
|
2028
|
2029
|
2030
|
|
Baseline
|
%
|
%
|
%
|
%
|
%
|
|
UK GDP1
|
0.4
|
1.1
|
1.4
|
1.4
|
1.5
|
|
UK unemployment2
|
5.3
|
5.3
|
5.0
|
4.9
|
4.9
|
|
UK HPI3
|
1.3
|
1.6
|
3.9
|
3.0
|
3.9
|
|
UK bank rate4
|
4.1
|
4.4
|
4.3
|
4.3
|
4.3
|
|
US GDP1
|
1.7
|
2.0
|
2.1
|
2.1
|
2.1
|
|
US unemployment5
|
4.4
|
4.3
|
4.3
|
4.3
|
4.3
|
|
US HPI6
|
2.1
|
2.1
|
2.4
|
2.4
|
2.4
|
|
US federal funds rate4
|
3.7
|
3.8
|
3.8
|
3.8
|
3.8
|
|
|
|
|
|
|
|
|
Downside 2
|
|
|
|
|
|
|
UK GDP1
|
(0.5)
|
(4.1)
|
1.9
|
1.7
|
1.0
|
|
UK unemployment2
|
6.0
|
7.8
|
7.8
|
6.9
|
6.0
|
|
UK HPI3
|
(12.0)
|
(19.3)
|
6.7
|
9.3
|
4.6
|
|
UK bank rate4
|
4.2
|
5.1
|
4.6
|
4.5
|
4.5
|
|
US GDP1
|
0.5
|
(4.3)
|
—
|
2.1
|
1.6
|
|
US unemployment5
|
5.5
|
8.5
|
8.3
|
7.2
|
6.1
|
|
US HPI6
|
(3.1)
|
(6.3)
|
5.7
|
5.0
|
2.9
|
|
US federal funds rate4
|
3.8
|
4.9
|
4.3
|
4.3
|
4.3
|
|
|
|
|
|
|
|
|
Downside 1
|
|
|
|
|
|
|
UK GDP1
|
(0.1)
|
(1.6)
|
1.6
|
1.5
|
1.2
|
|
UK unemployment2
|
5.6
|
6.6
|
6.4
|
5.9
|
5.4
|
|
UK HPI3
|
(5.4)
|
(9.2)
|
5.3
|
6.1
|
4.3
|
|
UK bank rate4
|
4.1
|
4.7
|
4.5
|
4.5
|
4.5
|
|
US GDP1
|
1.1
|
(1.2)
|
1.1
|
2.1
|
1.9
|
|
US unemployment5
|
5.0
|
6.4
|
6.3
|
5.8
|
5.2
|
|
US HPI6
|
(0.5)
|
(2.1)
|
4.0
|
3.7
|
2.7
|
|
US federal funds rate4
|
3.8
|
4.2
|
4.1
|
4.0
|
4.0
|
|
|
|
|
|
|
|
|
Upside 2
|
|
|
|
|
|
|
UK GDP1
|
0.9
|
3.8
|
3.2
|
2.6
|
2.3
|
|
UK unemployment2
|
5.1
|
4.6
|
4.1
|
4.0
|
4.0
|
|
UK HPI3
|
4.1
|
14.2
|
6.8
|
2.7
|
3.8
|
|
UK bank rate4
|
4.0
|
3.8
|
3.0
|
3.1
|
3.3
|
|
US GDP1
|
1.8
|
3.2
|
2.9
|
2.8
|
2.8
|
|
US unemployment5
|
4.2
|
3.7
|
3.6
|
3.6
|
3.6
|
|
US HPI6
|
4.9
|
4.3
|
5.3
|
4.9
|
4.9
|
|
US federal funds rate4
|
3.5
|
3.0
|
3.0
|
3.0
|
2.8
|
|
|
|
|
|
|
|
|
Upside 1
|
|
|
|
|
|
|
UK GDP1
|
0.6
|
2.4
|
2.3
|
2.0
|
1.9
|
|
UK unemployment2
|
5.2
|
4.9
|
4.6
|
4.5
|
4.5
|
|
UK HPI3
|
2.7
|
7.8
|
5.4
|
2.9
|
3.9
|
|
UK bank rate4
|
4.0
|
4.1
|
3.5
|
3.6
|
3.8
|
|
US GDP1
|
1.8
|
2.6
|
2.5
|
2.5
|
2.5
|
|
US unemployment5
|
4.3
|
4.0
|
4.0
|
4.0
|
4.0
|
|
US HPI6
|
3.5
|
3.2
|
3.8
|
3.6
|
3.6
|
|
US federal funds rate4
|
3.5
|
3.3
|
3.3
|
3.3
|
3.3
|
|
1
|
Average Real GDP seasonally adjusted change in
year.
|
|
2
|
Average UK unemployment rate 16-year+.
|
|
3
|
Change in year-end UK HPI = Halifax HPI Meth2 All Houses, All
Buyers index, relative to prior year-end.
|
|
4
|
Average rate.
|
|
5
|
Average US civilian unemployment rate 16-year+.
|
|
6
|
Change in year-end US HPI = FHFA House Price Index, relative to
prior year-end.
|
|
As at 31.12.25
|
2025
|
2026
|
2027
|
2028
|
2029
|
|
Baseline
|
%
|
%
|
%
|
%
|
%
|
|
UK GDP1
|
1.5
|
1.1
|
1.4
|
1.4
|
1.4
|
|
UK unemployment2
|
4.7
|
4.9
|
4.8
|
4.8
|
4.7
|
|
UK HPI3
|
1.5
|
2.9
|
2.5
|
4.3
|
3.8
|
|
UK bank rate4
|
4.2
|
3.4
|
3.4
|
3.5
|
3.6
|
|
US GDP1
|
2.1
|
2.0
|
2.0
|
2.0
|
2.0
|
|
US unemployment5
|
4.2
|
4.5
|
4.4
|
4.4
|
4.4
|
|
US HPI6
|
3.2
|
1.7
|
1.9
|
2.6
|
2.6
|
|
US federal funds rate4
|
4.2
|
3.4
|
3.3
|
3.3
|
3.5
|
|
|
|
|
|
|
|
|
Downside 2
|
|
|
|
|
|
|
UK GDP1
|
1.5
|
(2.5)
|
(1.2)
|
2.8
|
1.1
|
|
UK unemployment2
|
4.7
|
5.8
|
7.7
|
6.9
|
5.7
|
|
UK HPI3
|
1.5
|
(24.9)
|
(5.1)
|
9.6
|
14.2
|
|
UK bank rate4
|
4.2
|
2.3
|
0.5
|
0.4
|
1.1
|
|
US GDP1
|
2.1
|
(2.7)
|
(2.8)
|
1.6
|
2.4
|
|
US unemployment5
|
4.2
|
5.7
|
8.0
|
7.9
|
5.9
|
|
US HPI6
|
3.2
|
(8.2)
|
(1.7)
|
7.2
|
7.7
|
|
US federal funds rate4
|
4.2
|
3.6
|
2.4
|
1.4
|
1.2
|
|
|
|
|
|
|
|
|
Downside 1
|
|
|
|
|
|
|
UK GDP1
|
1.5
|
(0.7)
|
0.1
|
2.1
|
1.3
|
|
UK unemployment2
|
4.7
|
5.3
|
6.3
|
5.8
|
5.2
|
|
UK HPI3
|
1.5
|
(11.8)
|
(1.3)
|
6.9
|
8.9
|
|
UK bank rate4
|
4.2
|
2.9
|
2.0
|
1.9
|
2.4
|
|
US GDP1
|
2.1
|
(0.3)
|
(0.4)
|
1.8
|
2.2
|
|
US unemployment5
|
4.2
|
5.1
|
6.2
|
6.1
|
5.1
|
|
US HPI6
|
3.2
|
(3.3)
|
0.1
|
4.9
|
5.1
|
|
US federal funds rate4
|
4.2
|
3.6
|
2.8
|
2.4
|
2.4
|
|
|
|
|
|
|
|
|
Upside 2
|
|
|
|
|
|
|
UK GDP1
|
1.5
|
2.7
|
3.7
|
2.9
|
2.4
|
|
UK unemployment2
|
4.7
|
4.3
|
4.0
|
3.9
|
3.8
|
|
UK HPI3
|
1.5
|
11.9
|
8.4
|
5.1
|
4.1
|
|
UK bank rate4
|
4.2
|
3.1
|
2.3
|
2.3
|
2.6
|
|
US GDP1
|
2.1
|
2.8
|
3.1
|
2.8
|
2.8
|
|
US unemployment5
|
4.2
|
3.9
|
3.7
|
3.7
|
3.7
|
|
US HPI6
|
3.2
|
6.2
|
4.7
|
4.8
|
4.9
|
|
US federal funds rate4
|
4.2
|
3.0
|
2.5
|
2.5
|
2.5
|
|
|
|
|
|
|
|
|
Upside 1
|
|
|
|
|
|
|
UK GDP1
|
1.5
|
1.9
|
2.6
|
2.2
|
1.9
|
|
UK unemployment2
|
4.7
|
4.6
|
4.4
|
4.4
|
4.3
|
|
UK HPI3
|
1.5
|
7.4
|
5.4
|
4.7
|
3.9
|
|
UK bank rate4
|
4.2
|
3.2
|
2.8
|
2.8
|
3.1
|
|
US GDP1
|
2.1
|
2.4
|
2.6
|
2.4
|
2.4
|
|
US unemployment5
|
4.2
|
4.2
|
4.1
|
4.1
|
4.1
|
|
US HPI6
|
3.2
|
4.0
|
3.3
|
3.7
|
3.7
|
|
US federal funds rate4
|
4.2
|
3.3
|
2.8
|
2.8
|
3.0
|
|
1
|
Average Real GDP seasonally adjusted change in year.
|
|
2
|
Average UK unemployment rate 16-year+.
|
|
3
|
Change in year-end UK HPI = Halifax HPI Meth2 All Houses, All
Buyers index, relative to prior year-end.
|
|
4
|
Average rate.
|
|
5
|
Average US civilian unemployment rate 16-year+.
|
|
6
|
Change in year-end US HPI = FHFA House Price Index, relative to
prior year-end.
|
|
Scenario weighting
|
Upside 2
|
Upside 1
|
Baseline
|
Downside 1
|
Downside 2
|
|
|
%
|
%
|
%
|
%
|
%
|
|
As at 30.09.26
|
|
|
|
|
|
|
Scenario weighting
|
16.6
|
28.0
|
36.4
|
12.1
|
6.9
|
|
As at 30.06.26
|
|
|
|
|
|
|
Scenario weighting
|
13.7
|
27.3
|
39.5
|
12.5
|
7.0
|
|
As at 31.12.25
|
|
|
|
|
|
|
Scenario weighting
|
14.4
|
27.4
|
38.5
|
12.7
|
7.0
|
Treasury and Capital
Risk
Regulatory minimum
requirements
Capital
As at 30 September 2026, the Group’s Overall Capital
Requirement for CET1, excluding any applicable PRA buffer, was
12.2% and comprised a 4.5% Pillar 1 minimum, a 2.5% Capital
Conservation Buffer (CCB), a 1.5% Global Systemically Important
Institution (G-SII) buffer, a 2.7% Pillar 2A requirement and a 1.0%
Countercyclical Capital Buffer (CCyB).
The Group’s CCyB is based on the buffer rate applicable for
each jurisdiction in which the Group has exposures. The buffer
rates set by other national authorities for non-UK exposures are
not currently material.
The Group’s Pillar 2A requirement is 4.8% with at least
56.25% to be met with CET1 capital, equating to 2.7% of RWAs. The
Pillar 2A requirement, based on a point in time assessment, has
been set as a proportion of RWAs and is subject to at least annual
review.
The Group’s CET1 target ratio of 13-14% takes into account
minimum capital requirements and applicable buffers. The Group
remains above its minimum capital regulatory requirements and
applicable buffers.
Leverage
As at 30 September 2026, the Group was subject to a UK leverage
ratio requirement of 4.1%. This comprised the 3.25% minimum
requirement, a G-SII additional leverage ratio buffer (G-SII ALRB)
of 0.53% and a countercyclical leverage ratio buffer (CCLB) of
0.3%. The Group is also required to disclose an average UK leverage
ratio which is based on capital on the last day of each month in
the quarter and an exposure measure for each day in the
quarter.
MREL
As at 30 September 2026, the Group was required to meet the higher
of: (i) two times the sum of 8% Pillar 1 and 4.8% Pillar 2A
equating to 25.5% of RWAs; and (ii) 6.75% of leverage exposures.
CET1 capital cannot be counted towards both MREL and the buffers,
meaning that the buffers, including any applicable PRA buffer, will
effectively be applied above MREL requirements.
Significant regulatory updates in the period
In January 2026, the PRA confirmed the final implementation
timetable for the UK Basel 3.1 framework, reaffirming that Basel
3.1 will be implemented from 1 January 2027. From the same date,
the Group’s Overall Capital Requirement will reduce,
reflecting a 59bps reduction in the Pillar 2A requirement on a CET1
basis.
The PRA also confirmed its approach to the Fundamental Review of
the Trading Book (FRTB), under which implementation of the Internal
Models Approach (IMA) will be deferred to
1 January 2028, while all other FRTB components will
take effect from 1 January 2027.
|
Capital ratios
|
As at 30.09.26
|
As at 30.06.26
|
As at 31.12.25
|
|
CET1
|
14.2%
|
14.3%
|
14.3%
|
|
T1
|
17.8%
|
18.0%
|
17.9%
|
|
Total regulatory capital
|
19.9%
|
20.3%
|
20.4%
|
|
MREL ratio as a percentage of total RWAs
|
35.2%
|
36.7%
|
35.8%
|
|
|
|
|
|
|
Own funds and eligible liabilities
|
£m
|
£m
|
£m
|
|
Total equity excluding non-controlling interests per the balance
sheet
|
77,100
|
79,358
|
77,784
|
|
Less: other equity instruments (recognised as AT1
capital)
|
(13,275)
|
(13,275)
|
(12,725)
|
|
Adjustment to retained earnings for foreseeable ordinary share
dividends
|
(705)
|
(1,000)
|
(778)
|
|
Adjustment to retained earnings for foreseeable repurchase of
shares
|
(316)
|
—
|
(271)
|
|
Adjustment to retained earnings for foreseeable other equity
coupons
|
(45)
|
(38)
|
(36)
|
|
|
|
|
|
|
Other regulatory adjustments and deductions
|
|
|
|
|
Additional value adjustments (PVA)
|
(2,108)
|
(2,086)
|
(1,956)
|
|
Goodwill and intangible assets
|
(8,769)
|
(8,845)
|
(8,255)
|
|
Deferred tax assets that rely on future profitability excluding
temporary differences
|
(828)
|
(892)
|
(1,069)
|
|
Fair value reserves related to gains or losses on cash flow
hedges
|
3,936
|
1,548
|
666
|
|
Excess of expected losses over impairment
|
(618)
|
(505)
|
(436)
|
|
Gains or losses on liabilities at fair value resulting from own
credit
|
707
|
577
|
904
|
|
Defined benefit pension fund assets
|
(2,468)
|
(2,407)
|
(2,398)
|
|
Direct and indirect holdings by an institution of own CET1
instruments
|
(8)
|
(6)
|
(14)
|
|
Other regulatory adjustments
|
(237)
|
(186)
|
(346)
|
|
CET1 capital
|
52,366
|
52,243
|
51,070
|
|
|
|
|
|
|
AT1 capital
|
|
|
|
|
Capital instruments and related share premium accounts
|
13,286
|
13,286
|
12,758
|
|
Other regulatory adjustments and deductions
|
(10)
|
(10)
|
(33)
|
|
AT1 capital
|
13,276
|
13,275
|
12,725
|
|
|
|
|
|
|
T1 capital
|
65,642
|
65,519
|
63,795
|
|
|
|
|
|
|
T2 capital
|
|
|
|
|
Capital instruments and related share premium accounts
|
8,188
|
8,479
|
8,835
|
|
Qualifying T2 capital (including minority interests) issued by
subsidiaries
|
47
|
49
|
55
|
|
Other regulatory adjustments and deductions
|
(140)
|
(118)
|
(71)
|
|
Total regulatory capital
|
73,737
|
73,929
|
72,614
|
|
|
|
|
|
|
Less : Ineligible T2 capital (including minority interests) issued
by subsidiaries
|
(47)
|
(49)
|
(55)
|
|
Eligible liabilities
|
56,549
|
59,973
|
55,106
|
|
Total own funds and eligible
liabilities1
|
130,239
|
133,852
|
127,665
|
|
|
|
|
|
|
Total RWAs
|
369,753
|
364,764
|
356,774
|
|
1
|
As at 30 September 2026, the Group's MREL requirement, excluding
any applicable PRA buffer, was to hold £112.9bn of own funds
and eligible liabilities equating to 30.5% of RWAs. The Group
remains above its MREL regulatory requirement including any
applicable PRA buffer
|
|
Movement in CET1
capital
|
Three months ended 30.09.26
|
Nine months ended 30.09.26
|
|
|
£m
|
£m
|
|
Opening CET1 capital
|
52,243
|
51,070
|
|
|
|
|
|
Profit for the period attributable to equity holders
|
1,900
|
6,578
|
|
Own credit relating to derivative liabilities
|
(5)
|
3
|
|
Ordinary share dividends paid and foreseen
|
(500)
|
(1,500)
|
|
Purchased and foreseeable share repurchase
|
(1,000)
|
(2,500)
|
|
Other equity coupons paid and foreseen
|
(262)
|
(751)
|
|
Increase in retained regulatory capital generated from
earnings
|
133
|
1,830
|
|
|
|
|
|
Net impact of share schemes
|
153
|
44
|
|
Fair value through other comprehensive income reserve
|
(67)
|
34
|
|
Currency translation reserve
|
(36)
|
183
|
|
Other reserves
|
(12)
|
(20)
|
|
Increase in other qualifying reserves
|
38
|
241
|
|
|
|
|
|
Pension remeasurements within reserves
|
59
|
35
|
|
Defined benefit pension fund asset deduction
|
(60)
|
(70)
|
|
Net impact of pensions
|
(1)
|
(35)
|
|
|
|
|
|
Additional value adjustments (PVA)
|
(22)
|
(152)
|
|
Goodwill and intangible assets
|
76
|
(515)
|
|
Deferred tax assets that rely on future profitability excluding
those arising from temporary differences
|
64
|
241
|
|
Excess of expected loss over impairment
|
(113)
|
(182)
|
|
Direct and indirect holdings by an institution of own CET1
instruments
|
(2)
|
6
|
|
Other regulatory adjustments
|
(50)
|
(138)
|
|
Decrease in regulatory capital due to adjustments and
deductions
|
(47)
|
(740)
|
|
|
|
|
|
Closing CET1 capital
|
52,366
|
52,366
|
CET1 capital increased by £1.3bn to £52.4bn (December
2025: £51.1bn). Significant movements in the period
were:
● £6.6bn
of capital generated from profit partially offset by distributions
of £4.8bn comprising:
– £2.5bn
share buybacks including the now completed £1.5bn share
buyback announced with the FY25 and Q126 results and the ongoing
£1.0bn share buyback announced with Q226
results
– £1.5bn
of ordinary share dividends paid and foreseen reflecting the
£0.8bn half year dividend paid in September 2026 and a
£0.7bn accrual towards the total 2026
dividend
– £0.8bn
of equity coupons paid and foreseen
● £0.7bn
decrease due to regulatory adjustments and deductions including
£0.5bn of goodwill and intangibles deductions primarily driven
by the Best Egg acquisition
|
RWAs by risk type and
business
|
|||||||||||||
|
|
Credit risk
|
|
Counterparty credit risk
|
|
Market Risk
|
|
Operational risk
|
Total RWAs
|
|||||
|
|
STD
|
IRB
|
|
STD
|
IRB
|
Settlement Risk
|
CVA
|
|
STD
|
IMA
|
|
|
|
|
As at 30.09.26
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
|
£m
|
£m
|
|
Barclays UK
|
16,982
|
59,528
|
|
134
|
8
|
—
|
36
|
|
144
|
—
|
|
13,804
|
90,636
|
|
Barclays UK Corporate Bank
|
4,507
|
18,766
|
|
98
|
282
|
—
|
3
|
|
14
|
252
|
|
3,530
|
27,452
|
|
Barclays Private Bank & Wealth Management
|
5,104
|
588
|
|
126
|
21
|
—
|
11
|
|
36
|
170
|
|
2,062
|
8,118
|
|
Barclays Investment Bank
|
44,591
|
53,088
|
|
23,774
|
23,137
|
330
|
2,475
|
|
13,449
|
19,947
|
|
25,275
|
206,066
|
|
Barclays US Consumer Bank
|
17,966
|
967
|
|
—
|
—
|
—
|
—
|
|
—
|
—
|
|
5,394
|
24,327
|
|
Head Office
|
5,818
|
5,935
|
|
—
|
4
|
—
|
—
|
|
277
|
30
|
|
1,090
|
13,154
|
|
Barclays Group
|
94,968
|
138,872
|
|
24,132
|
23,452
|
330
|
2,525
|
|
13,920
|
20,399
|
|
51,155
|
369,753
|
|
As at 30.06.26
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Barclays UK
|
16,987
|
57,919
|
|
118
|
9
|
—
|
33
|
|
135
|
—
|
|
13,804
|
89,005
|
|
Barclays UK Corporate Bank
|
3,866
|
18,522
|
|
97
|
260
|
b —
|
3
|
|
16
|
274
|
|
3,530
|
26,568
|
|
Barclays Private Bank & Wealth Management
|
5,002
|
570
|
|
128
|
25
|
—
|
11
|
|
37
|
185
|
|
2,062
|
8,020
|
|
Barclays Investment Bank
|
44,721
|
51,050
|
|
25,723
|
22,591
|
336
|
2,566
|
|
12,110
|
19,772
|
|
25,275
|
204,144
|
|
Barclays US Consumer Bank
|
17,894
|
1,016
|
|
—
|
—
|
—
|
—
|
|
—
|
—
|
|
5,394
|
24,304
|
|
Head Office
|
5,538
|
5,883
|
|
1
|
4
|
—
|
—
|
|
175
|
32
|
|
1,090
|
12,723
|
|
Barclays Group
|
94,008
|
134,960
|
|
26,067
|
22,889
|
336
|
2,613
|
|
12,473
|
20,263
|
|
51,155
|
364,764
|
|
As at 31.12.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Barclays UK
|
16,731
|
55,037
|
|
132
|
8
|
—
|
43
|
|
177
|
—
|
|
13,697
|
85,825
|
|
Barclays UK Corporate Bank
|
3,878
|
18,341
|
|
89
|
312
|
1
|
4
|
|
31
|
343
|
|
3,510
|
26,509
|
|
Barclays Private Bank & Wealth Management
|
4,981
|
580
|
|
112
|
19
|
—
|
11
|
|
39
|
240
|
|
2,054
|
8,036
|
|
Barclays Investment Bank
|
44,961
|
49,750
|
|
21,986
|
19,442
|
165
|
3,030
|
|
12,018
|
20,111
|
|
25,238
|
196,701
|
|
Barclays US Consumer Bank
|
21,050
|
1,004
|
|
—
|
1
|
—
|
—
|
|
—
|
—
|
|
5,393
|
27,448
|
|
Head Office
|
5,405
|
5,439
|
|
1
|
5
|
—
|
—
|
|
219
|
59
|
|
1,127
|
12,255
|
|
Barclays Group
|
97,006
|
130,151
|
|
22,320
|
19,787
|
166
|
3,088
|
|
12,484
|
20,753
|
|
51,019
|
356,774
|
|
Movement analysis of
RWAs
|
Credit risk
|
Counterparty credit risk
|
Market risk
|
Operational risk
|
Total RWAs
|
|
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
RWAs as at 31.12.25
|
227,157
|
45,361
|
33,237
|
51,019
|
356,774
|
|
Book size
|
10,270
|
5,196
|
900
|
136
|
16,502
|
|
Acquisitions and disposals
|
(3,192)
|
—
|
—
|
—
|
(3,192)
|
|
Book quality
|
(574)
|
(61)
|
—
|
—
|
(635)
|
|
Model updates
|
—
|
(289)
|
—
|
—
|
(289)
|
|
Methodology and policy
|
(689)
|
29
|
—
|
—
|
(660)
|
|
Foreign exchange movements1
|
868
|
203
|
182
|
—
|
1,253
|
|
Total RWA movements
|
6,683
|
5,078
|
1,082
|
136
|
12,979
|
|
RWAs as at 30.09.26
|
233,840
|
50,439
|
34,319
|
51,155
|
369,753
|
|
1
|
Foreign exchange movements does not include the impact of foreign
exchange for modelled market risk or operational risk.
|
Total RWAs increased £13.0bn to £369.8bn (December 2025:
£356.8bn) primarily driven by:
Credit risk RWAs increased £6.7bn:
● A
£10.3bn increase in book size primarily reflecting lending
growth in UK businesses and increased lending within IB; partially
offset by
● A
£3.2bn decrease in acquisitions and disposals reflecting the
net impact of the AA portfolio exit and the Best Egg
acquisition
Counterparty credit risk RWAs increased £5.1bn primarily
driven by higher activity in Global Markets
|
Leverage ratios
|
As at 30.09.26
|
As at 30.06.26
|
As at 31.12.25
|
|
£m
|
£m
|
£m
|
|
|
UK leverage ratio1
|
4.9%
|
4.9%
|
5.1%
|
|
T1 capital
|
65,642
|
65,519
|
63,795
|
|
UK leverage exposure
|
1,344,015
|
1,345,596
|
1,247,313
|
|
Average UK leverage ratio
|
4.6%
|
4.6%
|
4.7%
|
|
Average T1 capital
|
64,449
|
63,787
|
63,277
|
|
Average UK leverage exposure
|
1,387,668
|
1,393,843
|
1,358,364
|
|
1
|
Although the leverage ratio is expressed in terms of T1 capital,
the leverage ratio buffers and 75% of the minimum requirement must
be covered solely with CET1 capital. The CET1 capital held against
the 0.53% G-SII ALRB was £7.1bn and against the 0.3% CCLB was
£4.0bn.
|
The UK leverage ratio decreased to 4.9% (December 2025: 5.1%)
primarily driven by a £96.7bn increase in leverage exposure to
£1,344.0bn (December 2025: £1,247.3bn), partially offset
by a £1.8bn increase in Tier 1 capital. The increase in
leverage exposure was driven by higher trading activity in Global
Markets and increased lending across the Group
Condensed Consolidated Financial
Statements
|
Condensed consolidated income
statement (unaudited)
|
||
|
|
Nine months
ended
30.09.26
|
Nine months
ended
30.09.25
|
|
|
£m
|
£m
|
|
Total income
|
23,866
|
22,063
|
|
Operating expenses excluding UK regulatory levies & litigation
and conduct
|
(13,438)
|
(12,661)
|
|
UK regulatory levies
|
(95)
|
(84)
|
|
Litigation and conduct
|
(92)
|
(342)
|
|
Operating expenses
|
(13,625)
|
(13,087)
|
|
Other net income
|
44
|
48
|
|
Profit before impairment
|
10,285
|
9,024
|
|
Credit impairment charges
|
(1,897)
|
(1,744)
|
|
Profit before tax
|
8,388
|
7,280
|
|
Tax charge
|
(1,791)
|
(1,538)
|
|
Profit after tax
|
6,597
|
5,742
|
|
|
|
|
|
Attributable to:
|
|
|
|
Shareholders of the parent
|
5,837
|
4,980
|
|
Other equity holders
|
741
|
739
|
|
Equity holders of the parent
|
6,578
|
5,719
|
|
Non-controlling interests
|
19
|
23
|
|
Profit after tax
|
6,597
|
5,742
|
|
|
|
|
|
Earnings per share
|
|
|
|
Basic earnings per ordinary share
|
43.0p
|
35.1p
|
|
Condensed consolidated balance sheet
(unaudited)
|
||
|
|
As at 30.09.26
|
As at 31.12.25
|
|
Assets
|
£m
|
£m
|
|
Cash and balances at central banks
|
253,290
|
229,752
|
|
Cash collateral and settlement balances
|
179,396
|
130,532
|
|
Debt securities at amortised cost
|
70,787
|
68,475
|
|
Loans and advances at amortised cost to banks
|
10,526
|
8,638
|
|
Loans and advances at amortised cost to customers
|
373,149
|
352,885
|
|
Reverse repurchase agreements and other similar secured lending at
amortised cost
|
12,051
|
17,622
|
|
Trading portfolio assets
|
215,985
|
190,061
|
|
Financial assets at fair value through the income
statement
|
201,717
|
186,857
|
|
Derivative financial instruments
|
308,971
|
252,459
|
|
Financial assets at fair value through other comprehensive
income
|
82,203
|
74,394
|
|
Investments in associates and joint ventures
|
751
|
739
|
|
Goodwill and intangible assets
|
8,994
|
8,284
|
|
Current tax assets
|
494
|
276
|
|
Deferred tax assets
|
5,654
|
4,992
|
|
Assets included in a disposal group classified as held for
sale
|
—
|
5,932
|
|
Other assets
|
13,612
|
12,267
|
|
Total assets
|
1,737,580
|
1,544,165
|
|
|
|
|
|
Liabilities
|
|
|
|
Deposits at amortised cost from banks
|
15,783
|
20,413
|
|
Deposits at amortised cost from customers
|
583,476
|
565,200
|
|
Cash collateral and settlement balances
|
178,471
|
117,583
|
|
Repurchase agreements and other similar secured borrowings at
amortised cost
|
29,269
|
25,170
|
|
Debt securities in issue
|
119,085
|
119,033
|
|
Subordinated liabilities
|
10,638
|
12,954
|
|
Trading portfolio liabilities
|
84,114
|
57,737
|
|
Financial liabilities designated at fair value
|
327,268
|
294,108
|
|
Derivative financial instruments
|
298,339
|
240,808
|
|
Current tax liabilities
|
992
|
868
|
|
Deferred tax liabilities
|
13
|
13
|
|
Other liabilities
|
12,578
|
12,042
|
|
Total liabilities
|
1,660,026
|
1,465,929
|
|
|
|
|
|
Equity
|
|
|
|
Called up share capital and share premium
|
4,171
|
4,178
|
|
Other equity instruments
|
13,275
|
12,725
|
|
Other reserves
|
(1,070)
|
1,628
|
|
Retained earnings
|
60,724
|
59,253
|
|
Total equity excluding non-controlling interests
|
77,100
|
77,784
|
|
Non-controlling interests
|
454
|
452
|
|
Total equity
|
77,554
|
78,236
|
|
|
|
|
|
Total liabilities and equity
|
1,737,580
|
1,544,165
|
|
Condensed consolidated statement of
changes in equity (unaudited)
|
|||||||
|
|
Called up share capital and share premium
|
Other equity instruments
|
Other reserves
|
Retained earnings
|
Total
|
Non-controlling interests
|
Total equity
|
|
Nine months ended 30.09.2026
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
Balance as at 1 January 2026
|
4,178
|
12,725
|
1,628
|
59,253
|
77,784
|
452
|
78,236
|
|
Profit after tax
|
—
|
741
|
—
|
5,837
|
6,578
|
19
|
6,597
|
|
Currency translation movements
|
—
|
—
|
183
|
—
|
183
|
—
|
183
|
|
Fair value through other comprehensive income reserve
|
—
|
—
|
34
|
—
|
34
|
—
|
34
|
|
Cash flow hedges
|
—
|
—
|
(3,270)
|
—
|
(3,270)
|
—
|
(3,270)
|
|
Retirement benefit remeasurements
|
—
|
—
|
—
|
35
|
35
|
—
|
35
|
|
Own credit
|
—
|
—
|
200
|
—
|
200
|
—
|
200
|
|
Total comprehensive income for the period
|
—
|
741
|
(2,853)
|
5,872
|
3,760
|
19
|
3,779
|
|
Employee share schemes and hedging thereof
|
127
|
—
|
—
|
603
|
730
|
—
|
730
|
|
Issue and redemption of other equity instruments
|
—
|
527
|
—
|
—
|
527
|
—
|
527
|
|
Other equity instruments coupon paid
|
—
|
(741)
|
—
|
—
|
(741)
|
—
|
(741)
|
|
Redemption of preference shares
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
|
Vesting of employee share schemes net of purchases
|
—
|
—
|
15
|
(963)
|
(948)
|
—
|
(948)
|
|
Dividends paid
|
—
|
—
|
—
|
(1,564)
|
(1,564)
|
(19)
|
(1,583)
|
|
Repurchase of shares
|
(134)
|
—
|
134
|
(2,469)
|
(2,469)
|
—
|
(2,469)
|
|
Other movements
|
—
|
23
|
6
|
(8)
|
21
|
2
|
23
|
|
Balance as at 30 September 2026
|
4,171
|
13,275
|
(1,070)
|
60,724
|
77,100
|
454
|
77,554
|
|
Three months ended 30.09.2026
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
Balance as at 1 July 2026
|
4,186
|
13,275
|
1,493
|
60,404
|
79,358
|
453
|
79,811
|
|
Profit after tax
|
—
|
254
|
—
|
1,646
|
1,900
|
—
|
1,900
|
|
Currency translation movements
|
—
|
—
|
(36)
|
—
|
(36)
|
—
|
(36)
|
|
Fair value through other comprehensive income reserve
|
—
|
—
|
(67)
|
—
|
(67)
|
—
|
(67)
|
|
Cash flow hedges
|
—
|
—
|
(2,388)
|
—
|
(2,388)
|
—
|
(2,388)
|
|
Retirement benefit remeasurements
|
—
|
—
|
—
|
59
|
59
|
—
|
59
|
|
Own credit
|
—
|
—
|
(134)
|
—
|
(134)
|
—
|
(134)
|
|
Total comprehensive income for the period
|
—
|
254
|
(2,625)
|
1,705
|
(666)
|
—
|
(666)
|
|
Employee share schemes and hedging thereof
|
18
|
—
|
—
|
124
|
142
|
—
|
142
|
|
Issue and redemption of other equity instruments
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
|
Other equity instruments coupon paid
|
—
|
(254)
|
—
|
—
|
(254)
|
—
|
(254)
|
|
Vesting of employee shares scheme net of purchases
|
—
|
—
|
26
|
(15)
|
11
|
—
|
11
|
|
Dividends paid
|
—
|
—
|
—
|
(795)
|
(795)
|
—
|
(795)
|
|
Repurchase of shares
|
(33)
|
—
|
33
|
(688)
|
(688)
|
—
|
(688)
|
|
Other movements
|
—
|
—
|
3
|
(11)
|
(8)
|
1
|
(7)
|
|
Balance as at 30 September 2026
|
4,171
|
13,275
|
(1,070)
|
60,724
|
77,100
|
454
|
77,554
|
|
|
As at As at 30.09.2026
|
As at As at 31.12.2025
|
|
Other Reserves
|
£m
|
£m
|
|
Currency translation reserve
|
2,676
|
2,493
|
|
Fair value through other comprehensive income reserve
|
(1,067)
|
(1,100)
|
|
Cash flow hedging reserve
|
(3,936)
|
(666)
|
|
Own credit reserve
|
(783)
|
(990)
|
|
Other reserves and treasury shares
|
2,040
|
1,891
|
|
Total
|
(1,070)
|
1,628
|
Appendix: Non-IFRS Performance
Measures
The Group’s management believes that the non-IFRS performance
measures included in this document provide valuable information to
the readers of the financial statements, as they enable the reader
to identify a more consistent basis for comparing the
businesses’ performance between financial periods, and
provide more detail concerning the elements of performance which
the managers of these businesses are most directly able to
influence or are relevant for an assessment of the Group. They also
reflect an important aspect of the way in which operating targets
are defined and performance is monitored by
management.
However, any non-IFRS performance measures in this document are not
a substitute for IFRS measures and readers should consider the IFRS
measures as well.
Non-IFRS performance measures glossary
|
Measure
|
Definition
|
|
|
Loan: deposit ratio
|
Loan: deposit ratio is calculated as total loans and advances at
amortised cost (including debt securities) divided by total
deposits at amortised cost.
|
|
|
Customer Loan: deposit ratio
|
Customer loans and advances at amortised cost divided by customer
deposits at amortised cost.
|
|
|
Period end tangible equity refers to:
|
|
|
|
Period end tangible shareholders' equity (for Barclays
Group)
|
Shareholders' equity attributable to ordinary shareholders of the
parent, adjusted for the deduction of goodwill and intangible
assets.
|
|
|
Period end allocated tangible equity (for businesses)
|
Allocated tangible equity is calculated as 13.5% (2025: 13.5%) of
RWAs for each business, adjusted for capital deductions, excluding
goodwill and intangible assets, reflecting the assumptions the
Barclays Group uses for capital planning purposes. Head Office
allocated tangible equity represents the difference between the
Barclays Group’s tangible shareholders’ equity and the
amounts allocated to businesses.
|
|
|
Average tangible equity refers to:
|
|
|
|
Average tangible shareholders’ equity (for Barclays
Group)
|
Calculated as the average of the previous month’s period end
tangible shareholders' equity and the current month’s period
end tangible shareholders' equity. The average tangible
shareholders’ equity for the period is the average of the
monthly averages within that period.
|
|
|
Average allocated tangible equity (for businesses)
|
Calculated as the average of the previous month’s period end
allocated tangible equity and the current month’s period end
allocated tangible equity. The average allocated tangible equity
for the period is the average of the monthly averages within that
period.
|
|
|
Return on tangible equity (RoTE) refers to:
|
|
|
|
Return on average tangible shareholders’ equity (for Barclays
Group)
|
Annualised Group attributable profit, as a proportion of average
tangible shareholders’ equity. The components of the
calculation have been included on page 71.
|
|
|
Return on average allocated tangible equity (for
businesses)
|
Annualised business attributable profit, as a proportion of that
business's average allocated tangible equity. The components of the
calculation have been included on pages 72 to 73.
|
|
|
|
|
|
|
Operating costs
|
A measure of total operating expenses excluding litigation and
conduct charges and UK regulatory levies.
|
|
|
Cost: income ratio
|
Total operating expenses divided by total income.
|
|
|
Loan loss rate
|
Quoted in basis points and represents total impairment charges
divided by total gross loans and advances held at amortised cost
(including portfolios reclassified to assets held for sale) at the
balance sheet date. The components of the calculation have been
included on pages 74 to 76.
|
|
|
Net interest margin
|
Annualised net interest income divided by the sum of average
customer assets. The components of the calculation have been
included on page 42.
|
|
|
Tangible net asset value per share
|
Calculated by dividing shareholders’ equity, excluding
non-controlling interests and other equity instruments, less
goodwill and intangible assets, by the number of issued ordinary
shares. The components of the calculation have been included on
page 79.
|
|
|
Profit before impairment
|
Calculated by excluding credit impairment charges or releases from
profit before tax.
|
|
|
Net New Assets Under Management
|
The net inflows and outflows of client balances within
Discretionary Portfolio Management and Advisory mandates. Excludes
market performance and foreign exchange translation but includes
reinvested dividend payments.
|
|
|
Assets under Management (AUM)
|
Total market value of client investment balances managed within
investment mandates where Barclays provides discretionary portfolio
management or advisory services. Total Assets Under Management
excludes uninvested cash held under an investment mandate and
reported within deposits.
|
|
|
Assets under Supervision (AUS)
|
Total market value of client investment balances where Barclays
provides custodian or transactional services.
|
|
|
Group net interest income excluding Barclays Investment Bank and
Head Office
|
A measure of Barclays Group net interest income, excluding the net
interest income reported in Barclays Investment Bank and Head
Office.
|
|
|
Income over average risk weighted assets
|
Represents total income as a proportion of average risk weighted
assets. Average risk weighted assets calculated as the average of
the previous month’s period end risk weighted assets and
the
current month’s period end risk weighted assets. Average risk
weighted assets for the period is the average of the monthly
averages within that period.
|
|
|
|
|
|
Returns
|
|
Nine months ended 30.09.26
|
|
|||||
|
|
Barclays UK
|
Barclays UK Corporate Bank
|
Barclays Private Bank and Wealth Management
|
Barclays Investment Bank
|
Barclays US Consumer Bank
|
Head Office
|
Barclays Group
|
|
Return on average tangible equity
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
Attributable profit/(loss)
|
1,880
|
606
|
216
|
3,035
|
521
|
(421)
|
5,837
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
|
Average equity
|
16.2
|
3.7
|
1.2
|
30.0
|
4.2
|
9.9
|
65.2
|
|
Average goodwill and intangibles
|
(3.9)
|
—
|
(0.1)
|
—
|
(0.7)
|
(3.9)
|
(8.6)
|
|
Average tangible equity
|
12.3
|
3.7
|
1.1
|
30.0
|
3.5
|
6.0
|
56.6
|
|
|
|
|
|
|
|
|
|
|
Return on average tangible equity
|
20.4%
|
21.6%
|
25.4%
|
13.5%
|
19.9%
|
n/m
|
13.8%
|
|
|
Nine months ended 30.09.25
|
|
|||||
|
|
Barclays UK
|
Barclays UK Corporate Bank
|
Barclays Private Bank and Wealth Management
|
Barclays Investment Bank
|
Barclays US Consumer Bank
|
Head Office
|
Barclays Group
|
|
Return on average tangible equity
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
Attributable profit/(loss)
|
1,737
|
480
|
256
|
2,798
|
246
|
(537)
|
4,980
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
|
Average equity
|
15.8
|
3.4
|
1.2
|
29.0
|
4.1
|
8.8
|
62.3
|
|
Average goodwill and intangibles
|
(4.0)
|
—
|
(0.1)
|
—
|
(0.6)
|
(3.6)
|
(8.3)
|
|
Average tangible equity
|
11.8
|
3.4
|
1.1
|
29.0
|
3.5
|
5.3
|
54.0
|
|
|
|
|
|
|
|
|
|
|
Return on average tangible equity
|
19.6%
|
18.8%
|
30.9%
|
12.9%
|
9.4%
|
n/m
|
12.3%
|
|
Barclays Group
|
|
|
|
|
|
|
|
|
|
|
|
Return on average tangible shareholders' equity
|
Q326
|
Q226
|
Q126
|
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
|
|
Attributable profit
|
1,646
|
2,259
|
1,932
|
|
1,195
|
1,457
|
1,659
|
1,864
|
|
965
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
|
Average shareholders' equity
|
65.3
|
64.8
|
65.5
|
|
64.8
|
63.3
|
62.1
|
61.4
|
|
59.7
|
|
Average goodwill and intangibles
|
(8.9)
|
(8.7)
|
(8.3)
|
|
(8.3)
|
(8.2)
|
(8.2)
|
(8.3)
|
|
(8.2)
|
|
Average tangible shareholders' equity
|
56.4
|
56.1
|
57.2
|
|
56.5
|
55.1
|
53.9
|
53.1
|
|
51.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Return on average tangible shareholders' equity
|
11.7%
|
16.1%
|
13.5%
|
|
8.5%
|
10.6%
|
12.3%
|
14.0%
|
|
7.5%
|
|
Barclays
UK
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
Q326
|
Q226
|
Q126
|
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
|
|
Attributable profit
|
666
|
623
|
591
|
|
706
|
647
|
580
|
510
|
|
781
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
|
Average allocated equity
|
16.5
|
16.2
|
15.9
|
|
15.9
|
15.9
|
15.8
|
15.7
|
|
15.1
|
|
Average goodwill and intangibles
|
(3.9)
|
(4.0)
|
(3.9)
|
|
(4.0)
|
(4.0)
|
(4.0)
|
(4.0)
|
|
(3.9)
|
|
Average allocated tangible equity
|
12.6
|
12.2
|
12.0
|
|
11.9
|
11.9
|
11.8
|
11.7
|
|
11.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
21.2%
|
20.4%
|
19.7%
|
|
23.8%
|
21.8%
|
19.7%
|
17.4%
|
|
28.0%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Barclays
UK Corporate Bank
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
Q326
|
Q226
|
Q126
|
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
|
|
Attributable profit
|
218
|
201
|
187
|
|
168
|
196
|
142
|
142
|
|
98
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
|
Average allocated equity
|
3.7
|
3.8
|
3.8
|
|
3.5
|
3.4
|
3.4
|
3.3
|
|
3.2
|
|
Average goodwill and intangibles
|
—
|
—
|
—
|
|
—
|
—
|
—
|
—
|
|
—
|
|
Average allocated tangible equity
|
3.7
|
3.8
|
3.8
|
|
3.5
|
3.4
|
3.4
|
3.3
|
|
3.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
23.5%
|
21.3%
|
19.9%
|
|
19.1%
|
22.8%
|
16.6%
|
17.1%
|
|
12.3%
|
|
Barclays Private Bank and Wealth
Management
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
Q326
|
Q226
|
Q126
|
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
|
|
Attributable profit
|
68
|
75
|
73
|
|
35
|
72
|
88
|
96
|
|
63
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
|
Average allocated equity
|
1.2
|
1.2
|
1.2
|
|
1.2
|
1.2
|
1.2
|
1.2
|
|
1.2
|
|
Average goodwill and intangibles
|
(0.1)
|
(0.1)
|
(0.1)
|
|
(0.1)
|
(0.1)
|
(0.1)
|
(0.1)
|
|
(0.1)
|
|
Average allocated tangible equity
|
1.1
|
1.1
|
1.1
|
|
1.1
|
1.1
|
1.1
|
1.1
|
|
1.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
23.8%
|
26.9%
|
25.5%
|
|
12.6%
|
26.4%
|
31.9%
|
34.5%
|
|
23.9%
|
|
Barclays Investment
Bank
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
Q326
|
Q226
|
Q126
|
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
|
|
Attributable profit
|
720
|
1,204
|
1,111
|
|
294
|
723
|
876
|
1,199
|
|
247
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
|
Average allocated equity
|
30.4
|
30.0
|
29.7
|
|
29.6
|
28.6
|
28.7
|
29.6
|
|
29.3
|
|
Average goodwill and intangibles
|
—
|
—
|
—
|
|
—
|
—
|
—
|
—
|
|
—
|
|
Average allocated tangible equity
|
30.4
|
30.0
|
29.7
|
|
29.6
|
28.6
|
28.7
|
29.6
|
|
29.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
9.5%
|
16.0%
|
15.0%
|
|
4.0%
|
10.1%
|
12.2%
|
16.2%
|
|
3.4%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Barclays US Consumer
Bank
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
Q326
|
Q226
|
Q126
|
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
|
|
Attributable profit
|
92
|
253
|
176
|
|
144
|
118
|
87
|
41
|
|
94
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
|
Average allocated equity
|
4.3
|
4.1
|
4.3
|
|
4.2
|
4.0
|
4.0
|
4.2
|
|
4.0
|
|
Average goodwill and intangibles
|
(0.9)
|
(0.8)
|
(0.5)
|
|
(0.6)
|
(0.5)
|
(0.6)
|
(0.6)
|
|
(0.6)
|
|
Average allocated tangible equity
|
3.4
|
3.3
|
3.8
|
|
3.6
|
3.5
|
3.4
|
3.6
|
|
3.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity
|
10.9%
|
30.2%
|
18.8%
|
|
15.8%
|
13.5%
|
10.2%
|
4.5%
|
|
11.2%
|
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rates
|
|
Nine months ended 30.09.26
|
|
|||||
|
|
Barclays UK
|
Barclays UK Corporate Bank
|
Barclays Private Bank and Wealth Management
|
Barclays Investment Bank
|
Barclays US Consumer Bank
|
Head Office
|
Barclays Group
|
|
Loan loss rate
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
Credit impairment (charges)/ releases
|
(461)
|
(21)
|
(8)
|
(356)
|
(1,053)
|
2
|
(1,897)
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
|
Gross loans and advances held at amortised cost (including
portfolios reclassified as held for sale)1
|
243.3
|
33.2
|
16.4
|
139.6
|
25.5
|
1.8
|
459.8
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate (bps)
|
25
|
8
|
7
|
34
|
552
|
n/m
|
55
|
|
|
Nine months ended 30.09.25
|
|
|||||
|
|
Barclays UK
|
Barclays UK Corporate Bank
|
Barclays Private Bank and Wealth Management
|
Barclays Investment Bank
|
Barclays US Consumer Bank
|
Head Office
|
Barclays Group
|
|
Loan loss rate
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
£m
|
|
Credit impairment (charges)/ releases
|
(339)
|
(36)
|
10
|
(283)
|
(1,090)
|
(6)
|
(1,744)
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
£bn
|
|
Gross loans and advances held at amortised cost (including
portfolios reclassified as held for sale)1
|
230.9
|
29.2
|
15.2
|
129.8
|
29.8
|
2.6
|
437.5
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate (bps)
|
20
|
16
|
(9)
|
29
|
489
|
n/m
|
53
|
|
1
|
Gross loans and advances at amortised cost comprises: loans and
advances to customers and banks at amortised cost, debt securities,
and portfolios reclassified as held for sale, gross of impairment
allowance, and is the denominator used in the LLR
metric.
|
|
Barclays Group
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate
|
Q326
|
Q226
|
Q126
|
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
|
|
Credit impairment charges
|
(503)
|
(571)
|
(823)
|
|
(535)
|
(632)
|
(469)
|
(643)
|
|
(711)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
|
Gross loans and advances held at amortised cost (including
portfolios reclassified as held for sale)1
|
459.8
|
450.4
|
449.9
|
|
441.3
|
437.5
|
428.4
|
430.4
|
|
429.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate (bps)
|
43
|
51
|
74
|
|
48
|
57
|
44
|
61
|
|
66
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Barclays UK
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate
|
Q326
|
Q226
|
Q126
|
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
|
|
Credit impairment charges
|
(123)
|
(160)
|
(178)
|
|
(74)
|
(102)
|
(79)
|
(158)
|
|
(283)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
|
Gross loans and advances held at amortised cost (including
portfolios reclassified as held for sale)1
|
243.3
|
239.8
|
233.6
|
|
231.9
|
230.9
|
228.5
|
227.5
|
|
227.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate (bps)
|
20
|
27
|
31
|
|
13
|
18
|
14
|
28
|
|
49
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Barclays UK Corporate
Bank
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate
|
Q326
|
Q226
|
Q126
|
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
|
|
Credit impairment charges
|
(2)
|
(16)
|
(3)
|
|
(1)
|
(5)
|
(12)
|
(19)
|
|
(40)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
|
Gross loans and advances held at amortised cost (including
portfolios reclassified as held for sale)1
|
33.2
|
31.4
|
31.0
|
|
30.2
|
29.2
|
28.2
|
27.0
|
|
25.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate (bps)
|
2
|
20
|
4
|
|
1
|
7
|
17
|
28
|
|
62
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Barclays Private Bank and Wealth
Management
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate
|
Q326
|
Q226
|
Q126
|
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
|
|
Credit impairment (charges)/releases
|
(5)
|
(5)
|
2
|
|
(2)
|
(1)
|
2
|
9
|
|
(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
|
Gross loans and advances held at amortised cost (including
portfolios reclassified as held for sale)1
|
16.4
|
15.1
|
15.1
|
|
15.1
|
15.2
|
14.8
|
14.8
|
|
14.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate (bps)
|
12
|
13
|
(6)
|
|
5
|
3
|
(5)
|
(25)
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
Gross loans and advances at amortised cost comprises: loans and
advances to customers and banks at amortised cost, debt securities,
and portfolios reclassified as held for sale, gross of impairment
allowance, and is the denominator used in the LLR
metric.
|
|
Barclays Investment
Bank
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate
|
Q326
|
Q226
|
Q126
|
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
|
|
Credit impairment charges
|
(33)
|
(44)
|
(279)
|
|
(22)
|
(144)
|
(67)
|
(72)
|
|
(46)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
|
Gross loans and advances held at amortised cost (including
portfolios reclassified as held for sale)1
|
139.6
|
137.2
|
137.4
|
|
131.0
|
129.8
|
126.8
|
129.6
|
|
124.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate (bps)
|
9
|
13
|
82
|
|
7
|
44
|
21
|
23
|
|
15
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Barclays US Consumer
Bank
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate
|
Q326
|
Q226
|
Q126
|
|
Q425
|
Q325
|
Q225
|
Q125
|
|
Q424
|
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
£m
|
|
£m
|
|
|
Credit impairment charges
|
(340)
|
(346)
|
(367)
|
|
(431)
|
(379)
|
(312)
|
(399)
|
|
(298)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
£bn
|
|
£bn
|
|
Gross loans and advances held at amortised cost (including
portfolios reclassified as held for sale)1
|
25.5
|
25.0
|
30.3
|
|
30.6
|
29.8
|
27.4
|
28.9
|
|
30.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate (bps)
|
529
|
555
|
491
|
|
558
|
505
|
456
|
562
|
|
395
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1
|
Gross loans and advances at amortised cost comprises: loans and
advances to customers and banks at amortised cost, debt securities,
and portfolios reclassified as held for sale, gross of impairment
allowance, and is the denominator used in the LLR
metric.
|
Income
over average RWAs
|
Barclays Investment
Bank
|
Nine months ended 30.09.26
|
Nine months ended 30.09.25
|
|
£m
|
£m
|
|
|
Income
|
11,115
|
10,263
|
|
|
|
|
|
|
£bn
|
£bn
|
|
Average RWAs
|
204.3
|
197.5
|
|
|
|
|
|
Income over average RWAs
|
7.3%
|
6.9%
|
|
Barclays Investment
Bank
|
Q326
|
Q226
|
Q126
|
|
Q425
|
Q325
|
Q225
|
|
Q125
|
Q424
|
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
£m
|
|
£m
|
£m
|
|
|
Income
|
3,129
|
3,958
|
4,028
|
|
2,792
|
3,083
|
3,307
|
|
3,873
|
2,607
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
£bn
|
|
£bn
|
£bn
|
|
Average RWAs
|
206.3
|
204.5
|
202.0
|
|
202.1
|
194.9
|
196.1
|
|
201.4
|
199.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income over average RWAs
|
6.1%
|
7.7%
|
8.0%
|
|
5.5%
|
6.3%
|
6.7%
|
|
7.7%
|
5.2%
|
|
Tangible net asset value per
share
|
As at 30.09.26
|
As at 31.12.25
|
As at 30.09.25
|
|
|
£m
|
£m
|
£m
|
|
Total equity excluding non-controlling interests
|
77,100
|
77,784
|
76,394
|
|
Other equity instruments
|
(13,275)
|
(12,725)
|
(13,243)
|
|
Goodwill and intangibles
|
(8,994)
|
(8,284)
|
(8,255)
|
|
Tangible shareholders' equity attributable to ordinary shareholders
of the parent
|
54,831
|
56,775
|
54,896
|
|
|
|
|
|
|
|
m
|
m
|
m
|
|
Shares in issue
|
13,379
|
13,867
|
13,996
|
|
|
|
|
|
|
|
p
|
p
|
p
|
|
Tangible net asset value per share
|
410
|
409
|
392
|
|
|
|
|
|
Shareholder
Information
|
Results timetable1
|
|
|
|
|
Date
|
|
|
2026 Full Year Results and Annual Report
|
|
|
|
|
9 February 2027
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% Change2
|
|
|
Exchange rates
|
30.09.26
|
31.12.25
|
30.09.25
|
|
31.12.25
|
30.09.25
|
|
Period end - GBP/USD
|
1.33
|
1.34
|
1.34
|
|
(1) %
|
(1) %
|
|
YTD average - GBP/USD
|
1.34
|
1.32
|
1.31
|
|
2 %
|
2 %
|
|
3 month average - GBP/USD
|
1.34
|
1.33
|
1.35
|
|
1 %
|
(1) %
|
|
Period end - GBP/EUR
|
1.17
|
1.15
|
1.15
|
|
2 %
|
2 %
|
|
YTD average - GBP/EUR
|
1.16
|
1.17
|
1.18
|
|
(1) %
|
(2) %
|
|
3 month average - GBP/EUR
|
1.17
|
1.14
|
1.15
|
|
3 %
|
2 %
|
|
|
|
|
|
|
|
|
|
Share price data
|
|
|
|
|
|
|
|
Barclays PLC (p)
|
458
|
476
|
380
|
|
|
|
|
Barclays PLC number of shares (m)3
|
13,379
|
13,867
|
13,996
|
|
|
|
|
|
|
|
|
|
|
|
|
For further information please contact
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investor relations
|
Media relations
|
|||||
|
Marina Shchukina +44 (0) 20 7116 2526
|
Tom Hoskin +44 (0) 20 7116 4755
|
|||||
|
|
|
|||||
|
More information on Barclays can be found on our website:
home.barclays
|
||||||
|
|
|
|
|
|
|
|
|
Registered office
|
|
|
|
|
|
|
|
1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20
7116 1000. Company number: 48839.
|
||||||
|
|
|
|
|
|
|
|
|
Registrar
|
|
|
|
|
|
|
|
Equiniti, Highdown House, Yeoman Way, Worthing, West Sussex, BN99
6DA, United Kingdom.
|
||||||
|
Tel +44 (0)371 384 2055 (UK and International telephone
number)4.
|
||||||
|
|
|
|
|
|
|
|
|
American Depositary Receipts (ADRs)
|
|
|
|
|
|
|
|
Computershare Shareowner Services, P.O. Box 43304, Providence, RI
02940-3304, United States of America
|
||||||
|
General Toll Free: +1-866-723-8257
|
||||||
|
General Direct: +1-781-575-2833
|
||||||
|
www.computershare.com/investor
|
||||||
|
|
|
|
|
|
|
|
|
Delivery of ADR certificates and overnight mail
|
||||||
|
Computershare Shareowner Services, 150 Royall Street, Suite 101,
Canton, MA 02021-1054
|
|
|
|
|||
|
|
|
|
|
|||
|
1
|
Note that this date is provisional and subject to
change.
|
|
2
|
The change is the impact to GBP reported information.
|
|
3
|
The number of shares of 13,379m as at 30 September 2026 is
different from the 13,372m quoted in the 1 October 2026
announcement entitled "Total Voting Rights" because the share
buyback transactions executed on 29 and 30 September 2026 did not
settle for cancellation until 1 and 2 October 2026
respectively.
|
|
4
|
Lines open 8.30am to 5.30pm (UK time), Monday to Friday, excluding
UK public holidays in England and Wales.
|